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Introduction: Camelid Diseases 
Camelids are a relatively recent addition to the domestic herbivores of North 
America. The first camelids were imported by multiple private owners in the 
1970s (llamas) and 1980s (alpacas),1 although the species already existed in 
select zoo populations. These unique animals have become more popular in the 
last several decades and their monetary value has been high.2 Meanwhile, their 
owners have struggled to find veterinarians with sufficient knowledge of camelid 
medical problems. In recent years there has been increasing study of the medical 
aspects of their unique metabolism as well as an interest in identifying their most 
common diseases. Little is known, however, about the true prevalence of camelid 
conditions or about which diseases are responsible for the majority of camelid 
morbidity and mortality. One study surveyed the causes of death in camelids 
submitted to the University of Guelph Animal Health Laboratory and identified 
digestive disorders as the most frequent cause of death in camelids, with 
neurologic diseases as the next most common cause of death.3 
 
Practitioners working with camelids report that they commonly encounter 
gastrointestinal parasitism, including strongyles,4 small coccidia and the more 
pathogenic large coccidia such as Eimeria macusaniensis,5-8 as well as 
cryptosporidiosis.9 In sufficient numbers and in combination with other stresses 
such as temperature extremes and competition for food, these gastrointestinal 
parasites can cause morbidity and mortality.10, 11 External parasites such as 
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Chorioptes are a common finding but are not expected to cause mortality.12, 13 
There is also concern about the potential for gastrointestinal conditions such as 
ulceration of the glandular portion of the third compartment14-16 or foreign body 
ingestion.17, 18 Congenital abnormalities such as choanal atresia19-23 or congenital 
heart defects24-26 can account for mortality in young crias. Meningeal worm is 
considered a major differential for a neurologic camelid, depending on 
geographic location,27-32 and polioencephalomalacia can occur under similar 
circumstances as in other ruminants.33-35 Lymphoma and other round cell tumors 
are the most commonly reported form of malignant neoplasia in camelids.15, 36-38 
 
Metabolic disorders such as hyperglycemia,39-41 hepatic lipidosis,42 hyperosmolar 
syndrome,39, 43 and hyperlipidemia44 can also cause morbidity and mortality in 
camelids. These metabolic derangements often occur as a secondary condition 
in sick and hospitalized camelids but can frequently be the medical issue that 
requires the most intensive treatment.45 The glucose and fat metabolism 
derangements seen in camelids are thought to be related to their unique 
properties of glucose and fat mobilization regulation,41, 46-51 in comparison to 
other species. Although camelids are forestomach fermenters, with the majority 
of their energy needs coming from short-chain fatty acids produced by microbial 
fermentation, their resting glucose levels are high compared to domestic 
ruminant species.46 The increased glucose levels observed in camelids are likely 
due to decreased insulin dependent uptake by muscle and adipose tissue in 
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comparison to other species.40, 41 This is supported by the fact that camelids 
have low resting levels of insulin, with fasting values ranging from approximately 
3-6 µU/ml,46, 52 compared to cattle with a range of 5-25 µU/ml. They have also 
been shown to clear glucose slowly from the bloodstream even after treatment 
with exogenous insulin.46-48 The distinctive glucose metabolism shown by New 
World camelids is proposed to be an adaptation to living in areas with poorly or 
intermittently available feed.41, 53  
 
Normal Pancreatic Function 
 
The endocrine pancreas is responsible for regulation of energy metabolism, 
including blood levels of glucose and lipids. Insulin is released from the ! cells of 
the pancreas in response to an increased blood glucose level. Insulin is the 
major energy storage hormone and has many functions, including the 
suppression of fat and glucose mobilization and enhancement of tissue uptake of 
energy substrates including glucose, non-esterified fatty acids (NEFAs), and 
amino acids.54 Glucagon is the catabolic hormone secreted by pancreatic " cells 
that acts to promote glycogenolysis and gluconeogenesis.55 Under normal 
circumstances, the opposing actions of insulin and glucagon maintain blood 
glucose in a narrow physiologic range. 
 
Glucose is the primary stimulus for insulin secretion, though other sources of 
energy (lipids, amino acids), hormones, and nitric oxide can also directly 
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stimulate insulin release.56 Glucose enters the ! cells via glucose transporter-2 
(GLUT-2) and is phosphorylated by glucokinase.57 The phosphorylated glucose 
is metabolized into pyruvate, ATP, and NADH by standard glycolytic pathways. 
Oxidation of NADH by the mitochondrial transport chain generates additional 
ATP and the high ratio of ATP to ADP in the ! cell inhibits ATP-sensitive 
potassium channels to cause depolarization of the cell membrane. This 
depolarization opens voltage-gated calcium channels and the calcium influx 
stimulates exocytosis of insulin-containing granules.56, 57 Insulin secretion follows 
a biphasic pattern with a large but short-lived rise in insulin levels following the 
initial stimulus and then a smaller but prolonged secondary phase of secretion.58 
In humans with type 2 diabetes mellitus, the first phase of insulin secretion in 
response to a glucose load is no longer present;59 however, other insulin 
secretogogues are still able to elicit a first phase response.60 
 
Once released, insulin binds to its receptor which is found on the cell surface of 
insulin-sensitive tissues such as muscle, adipose, and liver. In response to 
insulin binding at the " subunit, the receptor forms a dimer and is 
autophosphorylated, setting off a signaling cascade that results in many 
downstream effects, one of which is the translocation of the glucose transporter-4 
(GLUT4) molecule to the cell surface, primarily in muscle cells.61 This insulin-
dependent uptake of glucose by muscle cells is responsible for a large proportion 
of glucose disposal after a meal.54 
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Glucagon secretion is triggered by the generation of electrical signals by sodium 
and calcium channels that are active when blood glucose levels are low.62 
Glucagon binds to a G-protein coupled receptor on the surface of cells 
throughout the body but particularly in the liver, where it acts to stimulate 
gluconeogenesis by upregulating key enzymes in that pathway.63 Thus, defects 
in glucose homeostasis can be caused by decreased insulin secretion, lack of 
normal ! cell responsiveness to blood glucose levels, or peripheral insulin 
resistance, as well as abnormalities in glucagon secretion and " cell function. 
 
Endocrine Pancreatic Function Testing 
There are many methods by which to assess the function of the endocrine 
pancreas and the ability of the peripheral tissues to process glucose. Until 
recently, in humans, diabetes mellitus was diagnosed based on elevated levels 
of blood glucose, either after fasting or after an oral glucose challenge.64 An 
individual’s response to oral glucose tolerance testing depends on many factors, 
including intestinal absorption of glucose, pancreatic endocrine function, and 
peripheral insulin sensitivity. Due to the many possible sources of variation in 
response as well as greater convenience of testing, measurements of glycated 
hemoglobin (also known as A1C) have supplanted oral glucose testing as the 
diagnostic test of choice in humans.64 Although oral glucose tolerance testing has 
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been used in monogastric species including horses,65 it is not suitable for 
forestomach digesters.66 
 
Intravenous glucose tolerance testing (IVGTT) removes the variability of 
intestinal absorption from the analysis and assesses a combination of pancreatic 
endocrine function and peripheral insulin sensitivity. This method has been used 
in adult and juvenile camelids.46, 67 After an overnight fast, 0.5 g/kg of glucose is 
rapidly infused intravenously and blood glucose values are measured at 0, 1, 2, 
3, 4, 5, 15, 30, 60, 90, 120, 180, and 240 minutes after glucose infusion. In 
healthy animals of other species, the blood glucose value returns to normal less 
than 90 minutes of glucose infusion.68 However, in adult camelids blood glucose 
levels were still elevated 4 hours after glucose infusion, indicating slow glucose 
clearance attributable to a decreased insulin response to glucose load compared 
to other species.46 Llama crias demonstrated a stronger insulin response to 
IVGTT than adult camelids, though the fractional turnover rate of glucose was 
still lower than values observed in healthy cows.67 
 
Administration of exogenous insulin in the form of an insulin tolerance test (ITT) 
provides additional information about tissue uptake of glucose in response to 
insulin. After a 0.1 U/kg dose of regular insulin, blood glucose levels are 
expected to decrease by 50% within 30 minutes and return to baseline within 2 
hours.66 Insulin administration can also be coupled with glucose administration to 
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perform a combined glucose-insulin tolerance test (CGIT).69 A study in alpacas 
used a CGIT wherein 0.2 U/kg regular insulin was administered at T = 15 
minutes after a 0.5 g/kg glucose infusion. In that study, even with exogenous 
insulin, blood glucose levels remained elevated for 3 hours, demonstrating 
decreased peripheral insulin sensitivity.47 The half life of plasma glucose was 69 
minutes in camelids that received insulin compared to 111 minutes in those that 
did not. In comparison, healthy cows have a plasma glucose half life of 35 
minutes without the assistance of exogenous insulin.66 
 
All of the previous methods have the drawback that treatment with glucose and 
insulin can result in multiple competing processes, including glucose uptake into 
the tissues, release of endogenous insulin, and gluconeogenesis depending on 
the fluctuations in blood glucose. The hyperglycemic clamp (HGC) and the 
hyperinsulinemic euglycemic clamp (HEC) are techniques that have been 
developed in other species70 and performed in camelids51 that help to separate 
the components of systemic glucose production and disposal. Using the HGC, 
blood glucose levels are raised to supraphysiologic levels and maintained there 
for 2 hours to suppress endogenous glucose production.70 The rate of glucose 
infusion needed to maintain the predetermined blood glucose level depends on 
insulin secretion by the pancreas and thus is a measurement of ! cell sensitivity. 
During the HEC, a supraphysiologic level of insulin is infused at a constant rate 
to remove the contribution of the pancreas and the rate of glucose infusion is 
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adjusted to maintain euglycemia. Under these conditions, the rate of glucose 
needed is a measure of tissue insulin sensitivity. This method is considered the 
gold standard method for measurement of insulin sensitivity.70-72 In camelids, the 
rate of glucose required to maintain hyperglycemia during the HGC was lower 
than in horses73 or humans,70 indicating a comparatively decreased 
responsiveness of pancreatic ! cells to hyperglycemia.51 Similarly, the glucose 
infusion rate required to maintain euglycemic conditions during the HEC in 
camelids was roughly half of that needed in humans70 and cats,74 indicating 
relative peripheral insulin insensitivity.51 
 
Arginine Stimulation Testing 
The intravenous arginine stimulation test (IVAST) is an additional method to 
assess pancreatic endocrine " and ! cell function. Arginine is one of several 
pancreatic secretogogues that stimulate release of insulin and glucagon.60, 75, 76 
The transport of a positively-charged amino acid into the cell is thought to change 
the electrical gradient of the membrane and stimulate calcium influx, thereby 
promoting exocytosis of insulin-containing granules.77, 78 To perform the IVAST, a 
series of baseline measurements of glucose, insulin, and glucagon are taken, 
followed by intravenous infusion of arginine over 30 seconds. Blood samples are 
taken at T = 2, 3, 4, 5, 10, 15, and 20 minutes after infusion and glucose, insulin, 
and glucagon levels are measured at each time point.76 The hormone levels peak 
within 2-5 minutes,76, 79 providing an assessment of the first phase of insulin and 
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glucagon release.80 The IVAST can also be combined with a hyperglycemic 
clamp technique to assess pancreatic response at different blood glucose 
levels.81 It has been used extensively to evaluate both type 1 and type 2 diabetes 
mellitus in humans60, 75, 81-83 as well as veterinary species including foals,84-86 
cattle,87-91 and both normal and diabetic cats.92-94 In comparison to the more 
time-consuming clamp procedures, the IVAST is simple to perform and does not 
require maintenance of supraphysiologic glucose or insulin levels, and thus can 
be used to assess pancreatic function in clinical cases of disease. The IVAST 
has been successfully performed in healthy alpacas and llamas using the method 
described above with a dose of 67 mg/kg arginine.95 
 
Disorders of Camelid Lipid Metabolism 
New World camelids are also prone to developing disorders of fat mobilization 
such as hyperlipemia and hepatic lipidosis, even in the absence of risk factors 
such as pregnancy, lactation, or obesity.40, 42, 44, 96-98 A negative energy balance 
(due to feed restriction, anorexia, or increased demand) leads to fat mobilization, 
primarily in the form of non-esterified fatty acids (NEFAs) released from adipose 
tissue by the action of hormone sensitive lipase (HSL). NEFAs not used by 
peripheral tissues are processed in the liver to form ketone bodies such as !-
hydroxybutyrate (BHBA) as well as triglycerides (TGs). TGs are packaged as 
very-low-density lipoproteins (VLDLs) and are exported to the peripheral 
circulation, where lipoprotein lipase (LPL) releases the TGs to be used by 
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peripheral cells. Insulin inhibits the action of HSL and stimulates the action of 
LPL in order to decrease circulating fat fractions.99 In the face of low insulin levels 
or insulin resistance, as occurs in camelids, fat mobilization can spiral out of 
control, particularly because TGs themselves interfere with the normal function of 
insulin. High levels of TGs, NEFAs, and ketones cause anorexia and depression, 
and can cause hepatic lipidosis if the liver’s ability to process the excess fat 
becomes overwhelmed.99 
 
In camelids, fat mobilization can be induced under experimental conditions by 
treatment with epinephrine49 but not corticosteroids.52, 100 Treatment with 
corticosteroids was studied as a possible mechanism to induce fat mobilization 
because in other species corticosteroids have complex effects on lipid 
metabolism including increased expression of HSL, thereby releasing more 
NEFAs into circulation.101 Additionally, corticosteroids increase de novo 
lipogenesis within the liver and increase the exportation of VLDL.102 At the same 
time, corticosteroids cause peripheral and hepatic insulin resistance by 
inactivating insulin receptor proteins in skeletal muscle and by inducing 
expression of gluconeogenic enzymes in the liver.103 On the other hand, 
catecholamines stimulate HSL activity to promote fat breakdown and inhibit LPL, 
and at higher doses also suppress insulin release. One hour after a single 
treatment with epinephrine, levels of glucose, NEFAs, TGs, and BHBA 
increased,49 suggesting that epinephrine might play a role in the development of 
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hypertriglyceridemia and hyperlipemia in camelids. Treatment of camelids with 
short-acting insulin at the same time as epinephrine prevented the rise in NEFAs 
and delayed the increase in TGs and BHBA, indicating that insulin could be an 
effective treatment for disorders of fat mobilization, despite systemic insulin 
resistance.49 
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HYPOTHESES AND SPECIFIC AIMS 
OBJECTIVES: 
1. To describe the various causes of death in alpacas and llamas submitted to 
the University of Minnesota Veterinary Diagnostic Laboratory 




The camelid patient can present a diagnostic challenge to practitioners. A 
thorough description of the causes of mortality among alpacas and llamas in the 
Upper Midwest will provide a list of common differential diagnoses and will help 
identify specific aspects of husbandry and routine veterinary care that can be 
modified to reduce morbidity and mortality. 
 
Hypotheses 
Animals will present with a wide range of fatal disorders; however, the systems 
most commonly affected will be the digestive and nervous systems. 
 
Specific Aims 
a) To categorize diagnostic laboratory submissions by body system and 
pathophysiologic process 
b) To describe the range of diagnoses of alpacas and llamas submitted to the 
Veterinary Diagnostic Laboratory 
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c) To identify the most common causes of death in camelids submitted to the 





Understanding how pancreatic function changes in camelids in a state of fat 
mobilization will help guide treatment protocols to improve the ability of camelid 
practitioners to successfully treat sick animals. Pilot studies have shown that the 
arginine stimulation test can be performed on clinical cases without adverse 
effects. However, it is impractical to enroll a sufficient number of clinical cases 
and control for their individual variability. Epinephrine can be used to induce a 
transient state of fat mobilization in healthy camelids in order to study pancreatic 
function using the arginine stimulation test.  
 
Hypothesis 
Camelids in a state of epinephrine-induced fat mobilization will display a reduced 
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To use the arginine stimulation test to determine whether pancreatic ! and " cell 
responses to arginine differ between healthy camelids and those with 
epinephrine-induced fat mobilization. 
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Summary 
Knowledge of medical conditions that affect camelids has increased greatly in 
recent years. However, sometimes the first signs of illness in camelids can be 
subtle and nonspecific or animals may be found dead with no abnormalities 
observed. The purpose of this study was to catalog the fatal conditions seen in 
camelids in the Upper Midwest in order to recognize trends and ultimately to 
prevent disease. The reports of 234 alpacas and 125 llamas submitted to the 
University of Minnesota Veterinary Diagnostic Laboratory (UM!VDL) for 
post!mortem examination from 2001 to 2011 were reviewed. The cause of death 
was identified in 73% of the cases. The digestive system was the most common 
site of the major disease condition, accounting for 29% of alpacas and 31% of 
llamas. In adults, gastrointestinal parasitism associated with emaciation, 
neoplasia, and hepatic lipidosis were among the most common diagnoses 
identified. Meningeal worm (P. tenuis) was the most commonly identified cause 
of death associated with the nervous system in adults, since 13% of llamas and 
2.4% of alpacas had central nervous system lesions consistent with verminous 
migration. The most common cause of death or euthanasia among alpaca crias 
was choanal atresia, which accounted for mortality in 19% of alpacas under 6 
months of age. Other congenital abnormalities and bacterial infections were also 
common in neonates. In older crias (age 2 weeks to 6 months), enteritis and 
septicemia were most common. In conclusion, necropsy evaluation was 
successful in identifying the cause of death in the majority of camelids submitted 
to the UM!VDL. The risk of morbidity or mortality related to many of the most 
common diseases identified in this study can be reduced by taking steps to 
ensure good husbandry practices, including close monitoring of body condition 
score, regular fecal testing to identify parasite burdens, basic biosecurity 
measures to limit spread of pathogens, and IgG measurement to ensure 
adequate passive transfer of immunity. 
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Introduction 
New World camelids are a relatively recent addition to the herbivore fauna of 
North America. There are currently more than 200,000 registered alpacas 
(Alpaca Registry, Inc.) and more than 162,000 registered llamas (International 
Lama Registry) in the United States. As these animals have become more 
common in the last several decades, additional information has become available 
describing the medical conditions affecting alpacas and llamas. Diseased New 
World camelids may show only nonspecific signs of illness such as weakness or 
recumbency,104, 105 and antemortem diagnosis of many diseases can be difficult 
due to their stoic nature.17, 106 Therefore, postmortem examination is often  
necessary to attain an accurate diagnosis in these animals. 
 
Disease conditions commonly encountered in camelid practice include parasitism 
caused by endoparasites such as strongyles,4 small coccidia and large coccidia 
such as Eimeria macusaniensis,5-8, 107 cryptosporidia,9 and ectoparasites such as 
mange mites (Chorioptes sp.).12, 13 Camelids are also subject to non-infectious 
gastrointestinal conditions such as ulceration of the third compartment14-16, 108 or 
foreign body ingestion.17, 18 Congenital abnormalities that include conditions such 
as choanal atresia19-23 or labial fusion25, 109 are an important aspect of camelid 
disease. The most common neurologic diseases include meningeal worm 
infection (where the habitat of white-tailed deer and camelids overlap27, 29-32) and 
polioencephalomalacia.33-35 Lymphoma and other round cell tumors represent 
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the most common neoplastic diseases.15, 36-38 Important metabolic conditions 
include hepatic lipidosis,42, 97, 98 hyperosmolar syndrome,39, 43 and 
hyperlipidemia.44 However, little is known about which diseases are responsible 
for the majority of camelid mortality.  
 
Retrospective studies of necropsy examinations have been performed in other 
species and have provided a more complete understanding of their common 
disease processes.110-119 One report summarizing data from camelid necropsy 
submissions to Guelph’s Animal Health Laboratory has been published3 as has 
been a review of the gross pathology of camelids.15 Awareness of the most 
common fatal disorders in camelids may help identify specific aspects of 
husbandry or routine veterinary care that can be altered to prevent mortality and 
can also aid clinicians by narrowing the range of differential diagnoses for 
animals in recumbency. Additionally, regional differences in camelid diseases are 
known to occur and thus the aim of this retrospective study was to determine the 
causes of death observed in New World camelids submitted to a veterinary 
diagnostic laboratory for postmortem evaluation in the Upper Midwest region of 
the United States of America. 
 
Materials and Methods 
Necropsy records were reviewed from all alpaca and llama submissions to the 
University of Minnesota Veterinary Diagnostic Laboratory (UM-VDL). Only full 
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body necropsies that were performed between January 2001 and December 
2011 were included in this study. Three hundred and ninety-two carcasses were 
submitted by animal owners and private practice veterinarians as well as cases 
first presenting for referral treatment at the University of Minnesota Veterinary 
Medical Center (VMC). Submissions that were in a state of advanced autolysis 
were eliminated from the study (4 alpacas and 3 llamas). Furthermore, animals 
submitted as part of research studies (21 alpacas and one llama) and those 
donated for teaching followed by euthanasia were also excluded (3 alpacas and 
one llama).  
 
All postmortem examinations were performed at the UM-VDL under the 
supervision of veterinary pathologists. The necropsy included a gross 
examination and in most cases histopathologic evaluation. In general, the gross 
examination consisted of an assessment of the body condition score (BCS) using 
a 1 to 5 scoring system. Scoring was based on a system adapted for camelids120, 
and serous atrophy of bone marrow fat and/or coronary fat was used to identify 
animals with a score of 1. General findings were recorded. Body cavities and 
each body system (e.g. integument, respiratory, cardiovascular, alimentary, 
nervous) were dissected and evaluated. Samples of each system and lesions 
noted were fixed in 10% buffered formalin. Representative tissue sections were 
paraffin-embedded and examined histologically. Additional testing such as 
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bacterial culture, molecular analysis, and fecal flotation was performed if deemed 
necessary by the pathologist. 
 
The necropsy reports were examined retrospectively for this study. A variety of 
variables were recorded whenever available. These included age, sex (male, 
gelding, female), weight (kg), method of death (euthanized, died, or unknown), 
BCS (1 to 5), body system affected by disease (nervous, urogenital, 
musculoskeletal, respiratory, gastrointestinal, cardiovascular, hemic/lymphatic, 
systemic), gross and microscopic necropsy findings, presumptive cause of death, 
and results of fecal analysis, bacterial cultures, and molecular or serologic 
diagnostics, when performed. Gross or histologic diagnoses described by the 
pathologists were recorded using a predefined list of six-letter codes. The codes 
were defined by body system (e.g. nervous, cardiovascular, digestive). 
Diagnoses interpreted as incidental or agonal changes (such as lung congestion) 
were not recorded. The presumptive cause of death in each case was based on 
the magnitude and nature of the abnormalities noted as interpreted by the 




Animals were separated into the following age groups: fetus, neonate (<14 days), 
cria (2 weeks to 6 months), youngster (> 6 months to 18 months), adult (>18 
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months). Animals without specific ages listed on the report were included in the 
appropriate age group (e.g. adult) if age category could be determined from the 
necropsy report or by contacting the owner for additional information. Statistical 
analyses were conducted in R.a Categorical variables were presented as 
percentages and continuous variables were described as mean ± standard 
deviation or median. 
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I. Alpacas 
I.A: Alpaca Summary 
Two hundred and thirty-four necropsies were performed on alpacas over the 11 
years of the retrospective study. The mean age was 3.4 +/- 4.2 years old (range 
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0-22 years) and the median was 1.5 years. One hundred and thirty-five were 
female (58%), 69 were intact males (29%), 17 were neutered males (7%), 6 were 
unspecified males (2.5%), and 7 (3%) had no sex recorded. The median BCS 
was 2 out of 5. Sixty-six cases had no BCS recorded. Ninety-nine animals were 
submitted via the VMC (42%). One hundred nineteen cases died (51%), 60 were 
euthanized (26%), 28 cases were abortions (12%), and the method of death was 
unrecorded in 27 cases (12%). Forty-five alpacas (19%) were found dead without 
previous signs of illness reported by the owners and 26 were found recumbent 
(11%). The specific cause of death was determined in 166 cases (71%). Table 1 
and Figure 1 display the frequency of body system affected and Table 3 and 
Figure 3 show the distribution of pathophysiologic processes. 
 
I.B: Fetuses 
Thirty alpaca fetuses were submitted. Fifteen were female (50%), 12 were male 
(40%), and 3 (10%) had no sex recorded. 
 
The cause of abortion was considered idiopathic in 22 cases (73%). One 
submission was a pair of twins; death was thought to be caused by the 
unsustainability of a twin pregnancy. One fetus had an undifferentiated round cell 
tumor found throughout the body, including the heart, lung, liver, spleen, lymph 
nodes, and bone marrow. One was positive for bovine viral diarrhea virus 
(BVDV) by polymerase chain reaction. One submission had intranuclear 
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inclusion bodies identified in the placenta, but testing for bovine and equine 
herpesviruses by fluorescent antibody techniques performed on the lung, liver, 
and kidney and immunohistochemistry of the placenta and kidney yielded a 
negative result. One fetus had bilateral renal aplasia. One fetus was aborted after 
the dam underwent colic surgery and no specific lesions were identified. One 
fetus was aborted after surgical correction of a uterine torsion. 
 
I.C: Neonates 
Twenty-eight alpaca neonates (age 0 to 14 days) were submitted for postmortem 
examination. The mean age was 3.8 +/- 3.7 days and the median was 1.8 days. 
There was no numerical age recorded for 4 animals. Sixteen (57%) were female, 
11 (39%) were male, and 1 had no sex recorded. The mean weight was 7.1 +/- 
1.6 kg with a median of 6.8 kg (range 5.4-10.8 kg). Thirteen animals (46%) died, 
6 (21%) were euthanized, and no method of death was recorded for 9 animals 
(32%). Three neonatal alpacas were found dead without previous signs of illness 
reported by the owners (10%) and 1 was found recumbent (3%). The cause of 
death was identified in 25 cases (89%). 
 
Twelve animals in this age group (39%) had choanal atresia. Many had 
concurrent abnormalities in the olfactory bulb, cribiform plate, and eyes, and one 
also had a genital anomaly (fused labia). Two other animals had congenital 
malformations; one had multiple cardiac abnormalities and the other had 
abnormal lateral facets in the caudal cervical spine that were compressing the 
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spinal cord. There were 4 animals in which the digestive system was primarily 
affected. One had an intestinal perforation and peritonitis likely due to a 
penetrating foreign body. This animal also had hydronephrosis of the left kidney. 
One neonate had an enteritis due to infection with zygomycetes, suspected 
secondary to failure of passive transfer. One 10 day old neonate had 
cryptosporidiosis. Another animal had hemorrhagic and necrotizing inflammation 
of compartments 2 and 3 but the cause of the inflammation was not identified 
despite aerobic, anaerobic, and Salmonella cultures and electron microscopy of 
intestinal contents. There were 4 animals in which the respiratory system was 
primarily affected. Two had aspiration pneumonia; one of these was also 
septicemic and had hepatic lipidosis. One case of aspiration was related to 
feeding via nasoesophageal tube and the cause of aspiration could not be 
determined for the other. One neonate had pneumonia with Enterococcus sp. 
and Escherichia coli isolated from the lungs. Another animal was born 
approximately 30 days premature and had evidence of atelectasis consistent with 
prematurity and insufficient surfactant. One animal had evidence of myocardial 
degeneration possibly suggestive of ionophore toxicosis because liver vitamin E 
and selenium levels were considered adequate. One female neonate had a 
ruptured urinary bladder. One neonate had an E. coli septicemia with no obvious 
portal of entry. One neonate died due to exsanguination caused by umbilical 
artery hemorrhage. 
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I.D: Crias 
Thirty-eight alpaca crias (age 2 weeks to 6 months) were submitted for 
postmortem examination. The mean age was 2.5 +/- 1.5 months and the median 
was 2 months. Three animals (8%) had no numerical age recorded. Twenty-one 
cases were female (55%), 14 were intact male (37%), and 3 (8%) had no sex 
recorded. BCS ranged from 1 to 3 out of 5, though 9 had no BCS recorded. The 
median BCS was 1.5. The mean weight was 15.7 +/- 7.9 kg with a range of 6.1 to 
39 kg. Thirteen animals had no weight recorded. Twenty-four animals died 
(63%), 8 were euthanized (21%), and no method of death was recorded for 6 
animals (16%). Ten crias (26%) were found dead without previous signs of 
illness reported by the owners and 3 (8%) were found recumbent. The cause of 
death was determined in 30 cases (79%). 
 
A total of 8 animals (21%) had culture-confirmed septicemia as the cause of 
death and an additional 2 crias (5%) had histological changes consistent with 
septicemia but did not have positive cultures. Bacteria cultured included E. coli, 
Pasteurella sp., Klebsiella pneumoniae, Actinobacillus sp., Streptococcus sp., 
Staphylococcus sp., and Listeria monocytogenes. In three animals emaciation 
was considered the cause of death; underlying concurrent conditions included 
ulceration of the first compartment, giardiasis, and multiple intestinal parasitoses 
(coccidia, Nematodirus spp., and Trichuris spp.).  
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Five crias had primary musculoskeletal diagnoses. Two crias had congenital 
malformations of the cervical spine with spinal cord compression. One animal 
had a congenital absence of the intervertebral disc between lumbar vertebrae 1 
and 2. One animal had a Staphylococcus osteomyelitis and arthritis of the 
coxofemoral joint secondary to internal surgical fixation of a mid-diaphyseal 
femur fracture. One cria had skeletal muscle degeneration and necrosis with low 
liver selenium concentration (1 mcg/kg dry weight, normal range 1.2-2.5 mcg/kg) 
suggestive of white muscle disease. The respiratory system was primarily 
affected in three alpaca crias. One four-week old cria had choanal atresia with 
secondary aspiration pneumonia. One case had fibrinosuppurative and 
necrotizing pneumonia caused by Actinobacillus sp. and one case had a 
fibrinohemorrhagic bronchopneumonia with no specific cause recognized despite 
aerobic culture of tissues and immunohistochemistry of the lung to identify bovine 
respiratory syncytial virus as well as viral isolation from a tissue homogenate. 
One cria was euthanized for poor growth and depression and was diagnosed 
with a ventricular septal defect. One animal with severe pulmonary edema was 
euthanized for lack of response to treatment for Mycoplasma haemolamae. 
There were thirteen crias with the digestive system primarily affected. Five had 
parasitic enteritis; specific causes included a variety of pathogens such as 
Cryptosporidium sp., Eimeria macusaniensis, small coccidia, Moniezia sp., 
undifferentiated strongyles, and Nematodirus spp. Two animals had evidence of 
  29 
hepatic lipidosis without an identified underlying cause. One animal with a 
recorded age of 4 weeks had atresia coli. One cria had an esophageal 
obstruction with aspiration pneumonia. One animal died of Salmonella 
typhimurium enteritis with a concurrent coronavirus infection. One cria had 
necrosis of the second compartment with Clostridium perfringens type A isolated 
from the intestines and third compartment.  
 
There were three crias with primary neurologic diagnoses. One had 
Actinobacillus suis-associated encephalitis secondary to necrotizing stomatitis 
and sinusitis. One had a small brain abscess in the thalamus (approximately 1 
cm in diameter). Cultures were not performed and the route of infection was 
unclear. One case had encephalitis caused by Listeria monocytogenes. 
 
I.E: Youngsters 
Thirty-six alpacas (age 6 months to 18 months) were submitted for postmortem 
examination. The mean age was 11.9 +/- 4 months and the median was 12 
months. Two animals (6%) had no numerical age recorded. Twenty-two cases 
were female (63%) and 13 were intact males (37%). BCS ranged from 1 to 4 out 
of 5, though 11 had no numerical BCS recorded. The median BCS was 2. The 
mean weight was 40.6 +/- 12.9 kg with a range of 20 to 65 kg. Ten animals had 
no weight recorded. Twenty-two animals died (61%), 9 were euthanized (25%), 
and no method of death was recorded for 5 animals (14%). Eight cases (22%) 
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were found dead without previous signs of illness reported by the owners and 3 
(8%) were found recumbent. The cause of death was determined in 25 cases 
(69%). 
 
Emaciation (BCS = 1) was considered the cause of death of five of the 
youngsters. One of those had concurrent hepatic lipidosis, two had 
gastrointestinal parasites (coccidia and strongyles in one case and coccidia, 
Nematodirus spp., Trichuris sp., Capillaria sp., and strongyles in the other) that 
may have contributed to death. One of these had pericardial effusion, possibly 
related to hypoproteinemia. One of the youngsters died due to jugular vein 
trauma presumably caused by an animal attack. One had evidence of 
Actinobacillus sp. septicemia secondary to pneumonia. Two animals died after 
exploratory abdominal surgery with pulmonary edema and acute aspiration. 
 
Four animals had significant lesions of the cardiovascular system. Three cases 
had mural or valvular endocarditis; two of these cases had evidence of previous 
liver fluke infection. One animal died of pulmonary hemorrhage of an unknown 
cause. The hemolymphatic system was primarily affected in three alpaca 
youngsters. Two animals had multicentric round cell tumors; one of these was 
positive by immunohistochemistry for CD79, consistent with a B cell lymphoma, 
and the other was predominantly positive for CD3, consistent with a T cell 
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lymphoma. One animal was found dead in late August with multifocal 
subcutaneous hemorrhages; heat stroke was suspected. 
 
Thirteen animals had lesions primarily affecting the digestive system. Four had 
hepatic lipidosis; all four also had concurrent multifocal hemorrhage suggestive 
of a coagulation disorder. Two animals (aged 7 months and 12 months) had 
active liver fluke infection. Two animals had intussusceptions (one that was ileo-
ileal and one jejuno-jejunal) and one of those was positive for Salmonella 
enterica serotype Senftenberg. Two animals had hemorrhagic enteritis and 
Clostridium perfringens type A was isolated from intestinal contents of both 
cases; one isolate was positive for the !2 toxin gene on PCR. Another animal 
had enteric salmonellosis (Salmonella enterica serotype Newport). One case was 
found dead with peritonitis due to a foreign body induced intestinal perforation 
(fibrous plant matter). 
 
Three animals had primary urinary system abnormalities. One seven-month-old 
intact male was found dead with evidence of urethritis with luminal obstruction 
but no stone or plug was identified and bacterial culture from the urethra was 
negative. One ten-month-old intact male had an urachal abscess with secondary 
cystitis and pyelonephritis; Trueperella pyogenes was cultured from the abscess. 
A one-year-old male was euthanized for straining to urinate and suspected 
obstruction; however, the only abnormality identified was dilatation of the urinary 
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bladder and hypertrophy of the muscular layer of the bladder with no obvious 
cause. 
 
Four cases had primary nervous system abnormalities. Two cases had 
polioencephalomalacia. One animal had a five centimeter abscess compressing 
the cerebrum and another animal had suppurative meningitis. Bacterial culture 




One hundred and two adult alpacas (age > 18 months) were submitted for 
postmortem examination. The mean age was 6.5 +/- 4.1 years and the median 
was 5 years. Seven animals (7%) had no numerical age recorded. Sixty-one 
cases were female (60%), 19 were intact males (19%), 16 were geldings (16%), 
and 6 were unspecified males (6%). BCS ranged from 1 to 4.5 out of 5, though 
18 had no numerical BCS recorded. The median BCS was 2.25. Forty-two 
animals (41%) were underweight with a BCS of 2 or less. The mean weight was 
61.0 +/- 13.6 kg with a range of 31 to 97 kg. Twenty-five animals had no weight 
recorded. Fifty-eight animals died (57%), 37 were euthanized (36%), and no 
method of death was recorded for 7 animals (7%). Twenty-four cases (24%) 
were found dead without previous signs of illness reported by the owners and 19 
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(19%) were found recumbent. The cause of death was determined in 82 cases 
(80%). 
 
Emaciation was considered the cause of death in eleven of the adult alpacas 
(11%). Three of those had concurrent gastrointestinal parasitism, two (aged 10 
and 13 years) had dental abnormalities (uneven wear of the molar arcades in 
one case and severe incisor malalignment in the other), and one had hepatic 
lipidosis. Septicemia was considered the cause of death in six adults; 
Streptococcus spp. were isolated from four animals, while one animal each had 
E. coli and Listeria monocytogenes septicemia. One animal had peritonitis after 
exploratory abdominal surgery. One animal was found dead lodged in a fence 
with no other gross abnormalities on necropsy; suffocation was the presumed 
cause of death. 
 
Five animals had the musculoskeletal system primarily affected. Four had 
fractured bones. There was an animal with a fractured third cervical vertebra with 
spinal cord transection that was found dead, a case that was euthanized with a 
fractured third metacarpal, and a case that was euthanized for neurologic signs 
caused by a fractured tympanic bulla. One animal died due to fractures of the 
occipital condyles and the atlas that were possibly the result of an atlanto-
occipital malformation. One animal was euthanized with chronic lameness issues 
and had chronic proliferative bursitis of the right hock. 
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Five animals had primary respiratory diagnoses. Two animals had aspiration 
pneumonia; one of these was found dead several days after castration under 
general anesthesia. One animal had a food bolus lodged in its trachea. One 
animal had a granulomatous pneumonia that was negative for acid-fast 
organisms and one had an E. coli pneumonia with evidence of septicemia. 
 
The cardiovascular system was primarily affected in four cases. Two animals had 
endocarditis; one of those had concurrent liver fluke infection and bacterial 
culture was negative, while the other grew Acinetobacter sp. from the right 
ventricle.  One animal was found dead with a ventricular septal defect and 
pericardial effusion. One animal had fibrosis of the endocardium and myocardium 
of the right ventricle without a clear underlying cause. 
 
The hemolymphatic system was primarily affected in 14 animals. Eight adult 
alpacas had round cell tumors affecting multiple organs and lymph nodes; one of 
these had a concurrent Listeria monocytogenes septicemia. Three of the tumors 
were positive for CD20 on immunohistochemistry, which is consistent with B cell 
lymphoma. The other five tumors did not have consistent immunoreactivity to 
either B cell or T cell markers. Three adults had caseous lymphadenitis (CLA) 
abscesses and were culture positive for Corynebacterium pseudotuberculosis; 
two had both internal and external abscesses while one had only internal 
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abscesses. All three animals with CLA had abscessation of the liver; the lungs, 
heart, aorta, and portal vein each were affected in a single animal. Three animals 
had widespread petechiae of unknown pathogenesis and one of these also had 
hepatic lipidosis. 
 
The digestive system was primarily affected in 38 adult alpacas. Eight animals 
had a primary diagnosis of hepatic lipidosis. Seven had parasitic gastroenteritis; 
four had Eimeria macusaniensis, one had severe Haemonchus contortus 
infection, and two had a variety of parasites including undifferentiated strongyles, 
Nematodirus spp., Capillaria sp., Trichuris spp., and Moniezia sp. Six animals 
had intestinal obstructions; one had a spiral colon intussusception, one had a 
trichophytobezoar in the spiral colon, one had an adhesion of the jejunum to the 
urinary bladder, one had a foreign body in compartment 1, one had a stricture at 
the duodenal-pyloric junction after two foreign body surgeries, and one had a 
perforation of the spiral colon. There were four cases of intestinal neoplasia 
consisting of two small intestinal adenocarcinomas (one with metastasis to the 
lungs), a rectal carcinoma, and a leiomyoma of the first compartment. Two 
animals had severe third compartment ulcers; one of which was perforated in 
one animal. Two animals had ulcerative lesions in the first compartment and 
another had diphtheritic inflammation of the esophagus as well as compartments 
1 and 3; Fusobacterium sp. and Bacteroides sp. were cultured from the lesions in 
one of these animals. Pseudomonas aeruginosa was isolated from C1 in two of 
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the cases of first compartment ulceration. Two cases died shortly after abdominal 
surgery (one cesarean section, one abdominal exploratory) and 
lymphoplasmacytic enteritis was the most significant necropsy finding. One 
animal had portal hepatitis with fibrosis and one had a focal area of bile duct 
proliferation with no other significant lesions identified. One case had a liver fluke 
infection as the major cause of death. One animal had necrohemorrhagic 
enteritis with C. perfringens type A isolated (positive for the gene for !2 toxin) 
with concurrent coccidiosis. One animal had an impaction of the first 
compartment. One case had centrilobular liver necrosis; E. coli was isolated but 
the cause and significance of the liver lesion was undetermined. 
 
There were six animals with the urogenital system primarily affected. Two cases 
died or were euthanized with severe postpartum metritis 3-4 days after delivery. 
One animal died two days after a dystocia with uterine and vaginal perforation. 
One animal had a 17 kg periovarian abscess from which E. coli was isolated. 
Two cases died with chronic glomerulonephritis without specific underlying 
cause. 
 
The nervous system was primarily affected in ten cases. Five animals ranging in 
age from 4 to 12 years had eosinophilic inflammation and linear tracts in the 
central nervous system consistent with Parelaphostrongylus tenuis (meningeal 
worm) infection; 4 of the 5 cases involved the brain. There were two cases of 
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West Nile virus encephalitis and one of Eastern equine encephalitis. There was 
one animal with fungal osteomyelitis of the temporal bone resulting in 
encephalitis and compression of the cerebrum and cerebellum. The fungus was 
not cultured but the histologic appearance was consistent with Aspergillus sp. 
One animal had cerebral hemorrhage but the underlying cause was uncertain. 
 
I.G: Found Dead 
Forty-five alpacas were found dead without previous illness reported by their 
owners, comprising 19% of alpaca submissions. The mean age of alpacas 
suffering unexpected death was 4.7 +/- 5.0 years and the median was 4 years 
with a range of 2 days to 18 years. Six animals (13%) had no numerical age 
recorded. Eighteen cases were female (40%), 19 were intact males (42%), 5 
were geldings (11%), 2 were unspecified males (4%), and one had no sex 
recorded (2%). BCS ranged from 1 to 4.5 out of 5, though 8 had no numerical 
BCS recorded. The median BCS was 2. The cause of death was determined in 
34 cases (76%). 
  
The most common cause of unexpected death in alpacas was emaciation, 
accounting for 8 cases (18%). Parasitic infections were the next most frequent 
cause of sudden death, affecting 7 cases; three animals had massive liver fluke 
infections, one had a meningeal worm infection, one had Cryptosporidium sp. 
infection, one had Eimeria macusaniensis, and one was infected with a variety of 
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gastrointestinal parasites. Six died from bacterial infections, including three cases 
of pneumonia, two cases of neonatal sepsis, and one case of Actinobacillus suis 
encephalitis. There were five cases of neoplasia that resulted in death without 
previously noted clinical signs (three round cell tumors and two small intestinal 
carcinomas), and five traumatic causes of death (including suffocation, spinal 
fracture, and animal attack). There were three cases of hepatic lipidosis. 
 
I.H: Found Recumbent 
Twenty-six alpacas were found recumbent (11%). The mean age of down 
alpacas was 5.0 +/- 4.3 years and the median was 4 years with a range of 9 days 
to 18 years. There was one animal with no numerical age recorded. Fourteen 
cases were female (54%), 6 were intact males (23%), 5 were geldings (19%), 
and one was an unspecified male (4%). BCS ranged from 1 to 4 out of 5 with a 
median of 2.25, though 8 had no numerical BCS recorded. The cause of death 
was determined in 21 cases (81%). 
 
There were a wide variety of ultimate causes of death in animals that were found 
down; however, gastrointestinal parasites accounted for 4 cases, including 
infection with Eimeria macusaniensis, Haemonchus contortus, and small 
coccidia. There were two cases each of emaciation, round cell tumors, West Nile 
virus, widespread hemorrhage consistent with a coagulation disorder, and 
meningeal worm. The nervous system was affected in only 5 of the 26 animals 
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found down (19%), while the digestive system was primarily affected in 11 cases 
(42%). 
 
I.I: Ancillary Testing 
One hundred and ninety-five animals had aerobic cultures performed on swabs 
of organs and/or serosal surfaces (83%). Sixty-seven cultures were positive and 
a wide range of bacteria were isolated, including Enterococcus sp., 
Staphylococcus spp., Streptococcus spp., Listeria monocytogenes, Trueperella 
pyogenes, Actinobacillus spp., Actinomyces spp., E. coli, Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Bordetella bronchiseptica, and Acinetobacter 
sp. Sixty-three anaerobic cultures were performed (27%). Forty-three cultures 
were positive, including 36 cultures of intestinal contents which isolated 
Clostridium perfringens, two endocarditis lesions and one aortic abscess that 
were positive for Peptostreptococcus anaerobius, two esophageal swabs that 
grew Fusobacterium necrophorum, and one liver swab that was positive for 
Clostridium sordelli. One hundred and twenty-six Salmonella cultures were 
performed on pooled tissue samples (54%) and five samples were positive (one 
cria, 2 youngsters, and 2 adults; 2% of alpacas). The isolation of Salmonella may 
have been incidental in the two adult alpacas (who died of Eastern equine 
encephalitis and emaciation).  However, Salmonella appeared to cause disease 
in the younger animals, where it was considered the cause of fatal enteritis in two 
cases and was isolated from an animal with an intussusception. Eighteen 
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animals were tested for Mycobacterium avium subsp. paratuberculosis by fecal 
PCR (8%) and all were negative.  
 
One hundred and thirty-nine animals were tested for bovine viral diarrhea virus 
(BVDV) by PCR (59%) and the one positive specimen was an aborted fetus. 
Fifteen animals (6%) were tested for rabies by the direct fluorescent antibody test 
and all were negative. Nine cases (4%) were tested for viral encephalitides and 
three (all adults) were positive for Eastern equine encephalitis virus and West 
Nile virus. Forty-six cases (20%) were tested for viruses by electron microscopy 
of intestinal contents and four were positive; there was one diagnosis each for 
coronavirus, adenovirus, enterovirus, and one small unidentified virus. The 
significance of these observed viruses is unclear. Eight abortion cases 
underwent viral isolation by passage on bovine turbinate cells or other tests for 
viral pathogens other than bovine diarrhea virus; all were negative. 
 
Fecal flotations were performed on one hundred and forty-nine cases (64%) and 
82 were positive (55% of floats performed). A variety of gastrointestinal parasites 
were identified, including small coccidia, Eimeria macusaniensis, 
Cryptosporidium spp., Giardia sp., undifferentiated strongyles, Nematodirus spp., 
Trichuris spp., Capillaria sp., and Moniezia sp.. Twenty-four immunofluorescence 
assays for Cryptosporidium sp. and Giardia sp. were performed (10%) and a 
single 4-month-old alpaca was positive. 
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II. Llamas 
II.A: Llama Summary 
One hundred and twenty-five necropsies were performed on llamas over the 11 
years of the retrospective study. The mean age was 6.7 +/- 5.2 years old (range 
0-20 years) and the median was 5.5 years. Sixty-seven of the llamas were 
female (54%), 8 were intact males (6%), 29 were neutered males (23%), 11 were 
unspecified males (1%), one was a hermaphrodite (1%), and 9 (7%) had no sex 
recorded. The median BCS was 2 of out 5. Fifty cases had no BCS recorded. 
Fifty-two cases died (42%), 44 were euthanized (35%), 2 cases were abortions 
(2%), and the method of death was unrecorded in 27 cases (22%). Thirty llamas 
were found dead (24%) without previous signs of illness reported by the owners 
and 29 were found recumbent (23%). The specific cause of death was 
determined in 104 cases (83%). Table 2 and Figure 2 display the frequency of 





There were 3 llama fetuses submitted. If there was any evidence that the animal 
had breathed (aerated lung), it was classified as a neonate and not included in 
this group (one case). Two were female (67%) and one was male (33%).  
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The cause of abortion was considered idiopathic in 2 cases (67%). One of these 
cases had hemoperitoneum with no underlying cause identified and the other 
had no gross abnormalities. The third fetus was found dead and partially 
delivered and was considered to have died from asphyxia. 
 
II.C: Neonates 
Five llama neonates (age 0 to 14 days) were submitted for postmortem 
examination. The mean age was 4.5 +/- 4.0 days and the median was 5.1 days. 
Three (60%) were female, one (20%) was male, and one had no sex recorded. 
The range of weight was 9 to 10 kg and three animals had no weight recorded. 
Three animals (60%) died, one (20%) was euthanized, and no method of death 
was recorded for one animal (20%). The cause of death was identified in all 5 
cases. 
 
One llama neonate died of Actinobacillus sp. septicemia with pneumonia, 
meningitis, and laryngitis. One case died at one day of age with a ventricular 
septal defect with an overriding aorta and a patent ductus arteriosus. One animal 
was euthanized at 5 days of age with a meconium impaction. One case died 
during dystocia but had no other abnormalities identified; it was classified as a 
neonate rather than a fetus by the pathologist. The remaining case had 
suppurative meningitis and encephalitis; Enterobacter sp. and Haemophilus sp. 
were isolated. 
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II.D: Crias 
Five llama crias (age 2 weeks to 6 months) were submitted for postmortem 
examination. The mean age was 4.0 +/- 1.9 months and the median age was 5 
months. Three cases were female (60%), one was an intact male (20%), and one 
(20%) had no sex recorded. BCS ranged from 1 to 3 out of 5, though two had no 
BCS recorded. The median BCS was 1.5. The weight ranged from 14 to 43 kg 
but three animals had no weight recorded. Two animals died (40%), two were 
euthanized (40%), and no method of death was recorded for one animal (20%). 
Two cases (40%) were found dead without previous signs of illness reported by 
the owners and one (20%) was found recumbent. The cause of death was 
determined in 4 cases (80%). 
 
Emaciation was considered the cause of death in one case that had concurrent 
infection with Trichuris spp. and undifferentiated strongyles. One case had a 
subluxation of the fifth cervical vertebra that was thought to be congenital. One 
case had marked Haemonchus contortus infection of the third compartment and 
was anemic and emaciated. One llama cria had Listeria monocytogenes 
septicemia. The last case was anemic and had acidosis of the first compartment 
but no specific cause of death was identified. 
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II.E: Youngsters 
Eleven llamas aged 6 months to 18 months were submitted for postmortem 
examination. The mean age was 13 +/- 3 months and the median was 12 
months. One animal (9%) had no numerical age recorded. Six cases were 
female (55%), three (27%) were intact males, one (9%) was a gelding, and one 
(9%) had no sex recorded. BCS ranged from 1 to 3 out of 5 and one animal had 
no BCS recorded. The median BCS was 1.75. The mean weight was 55.4 +/- 
20.7 kg with a range of 28 to 91 kg. Two animals had no weight recorded. Six 
animals died (55%) and five were euthanized (45%). Five cases (45%) were 
found dead and one (9%) was found recumbent. The cause of death was 
determined in 10 cases (91%). 
 
One case had degeneration of the heart muscle but no specific cause was 
identified; histology of skeletal muscle was within normal limits and feed samples 
were negative for ionophores. One case had an Actinobacillus sp. arteritis that 
eroded into the lung and caused fatal pulmonary hemorrhage. Liver flukes 
(Fascioloides magna) were the cause of death in four llama youngsters. Two 
other cases had marked gastrointestinal parasitoses; Haemonchus contortus 
accounted for one case and a large Moniezia burden along with Trichuris sp. and 
strongyles was observed grossly in the other. One llama youngster had 
ulceration of the first compartment. One case was euthanized for poor response 
after a tube cystotomy for obstructive urolithiasis and had a ruptured bladder due 
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to necrosis of the surgical site. One llama aged 14 months had spinal cord 
lesions consistent with Parelaphostrongylus tenuis migration. 
 
II.F: Adults 
One-hundred and one adult llamas (age > 18 months) were submitted for 
postmortem examination. The mean age was 8.2 +/- 4.7 years and the median 
age was 7.5 years. Fifteen animals (15%) had no numerical age recorded. Fifty-
three cases were female (52%), 3 were intact males (3%), 28 were geldings 
(28%), 10 were unspecified males (10%), one was a hermaphrodite (1%), and 
the sex was not recorded for six cases (6%). BCS ranged from 1 to 4.5 out of 5, 
though 41 had no numerical BCS recorded. The median BCS was 2.5. Twenty-
nine animals (29%) were underweight with a BCS of 2 or less. The mean weight 
was 133 +/- 43 kg with a range of 56 to 260 kg. Forty-seven animals had no 
weight recorded. Forty animals died (40%), 36 were euthanized (36%), and no 
method of death was recorded for 25 animals (25%). Twenty-two cases (22%) 
were found dead and 27 (27%) were found recumbent. The cause of death was 
determined in 84 cases (83%). 
 
Emaciation was considered the cause of death in twelve adult llamas. Seven of 
these had gastrointestinal parasites (namely Trichuris sp. but also strongyles; 
one also had Fascioloides magna), two had dental abnormalities, two had fungal 
rhinitis, stomatitis, and/or pharyngitis, and one had ulceration of the first 
  46 
compartment. A multisystemic primary cause of death was identified in another 
seven animals. The cause of death in one case was Streptococcus equi subsp. 
zooepidemicus septicemia with concurrent hepatic lipidosis. The cause of death 
for one animal was polyserositis and cystitis without a bacterial cause identified. 
There were two cases of suspected toxicity, one of copper overload (299.4 ppm 
wet weight, normal range 30-100 ppm wet weight)121 and one with lead exposure 
(liver lead value 2.9 ppm wet weight). Other causes of death included one case 
of Actinomyces spp. and Clostridium sordelli and perfringens peritonitis 
secondary to liver fluke infection, and one case of a traumatic body wall 
herniation with hemoabdomen. One case was found dead with no significant 
abnormalities; heat stroke was suspected.  
 
The integumentary system was primarily affected in two adult llamas. One llama 
had squamous cell carcinoma of the mammary gland area with metastasis to the 
sublumbar lymph nodes and lungs as well as secondary abscessation of the skin 
tumors. One animal was found dead with marked Chorioptes infestation; 
however, no cause of death could be identified and tests for strychnine were 
negative. 
 
The musculoskeletal system was primarily affected in five adult llamas. There 
were two spinal fractures: one at the sixth cervical vertebra with concurrent 
suppurative osteomyelitis and one at T12-L1. The latter case also had evidence 
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of linear tracts in the spinal cord consistent with meningeal worm infection, which 
may have caused ataxia that predisposed the animal to trauma. Three animals 
were euthanized for chronic lameness issues; one had bilateral rupture of the 
lateral collateral ligaments of the stifle, one had chronic arthritis and osteomyelitis 
of the carpal joint, and one had ankylosis of the tibiotarsal joint. 
 
The respiratory system was primarily affected in eight adult llamas. There were 
three cases with changes suggestive of chronic obstructive pulmonary disease. 
These findings included hyperinflated and resilient lungs on gross examination 
with lymphocytic peribronchiolitis, hyperplasia of bronchiolar smooth muscle, and 
interstitial and alveolar fibrosis seen histologically. No bacteria, fungi, 
Mycoplasma species, or viruses were isolated from these three cases. There 
were two cases of aspiration pneumonia, one pneumonia caused by a Bacillus 
sp., one case with pulmonary edema of unknown cause, and one chronic 
interstitial pneumonia with no identified underlying cause. 
 
Five adult llamas had a primary lesion in the cardiovascular system. Two animals 
had a ruptured pulmonary artery that resulted in cardiac tamponade. There were 
two cases from one farm with degeneration of the heart muscle; ionophore 
toxicosis was suspected but feed samples tested negative. One case had a 
focally extensive area of fibrosis in the left ventricular free wall that was 
considered to be the cause of death. 
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The hemolymphatic system was primarily affected in three adult llamas. There 
were two cases of multicentric round cell tumors. One was described as a well 
differentiated lymphosarcoma but no immunohistochemistry was performed.  
One was immunonegative when using standard markers for leukocytes including 
lysozyme, CD79, and Mac387, was negative for cytokeratin, and was variably 
positive for vimentin and CD3; the pathologist’s conclusion was that the tumor 
origin could not be identified based on the tests performed. There was one case 
of caseous lymphadenitis with internal abscessation that was culture positive for 
Corynebacterium pseudotuberculosis; abscesses were found in the lungs, heart, 
kidneys, and brain. 
 
The digestive system was primarily affected in 30 cases. There were seven 
cases of liver fluke infection (Fascioloides magna). Seven animals had marked 
compartment 3 ulcers, two of which were perforated. Three cases had dilation 
and impaction of compartment 1 and one of these also had megaesophagus. 
There were two cases of intestinal volvulus, both affecting the spiral colon. Two 
cases had ulcerative inflammation of the esophagus and the first compartment of 
the stomach but no underlying cause was identified. Two cases died of intestinal 
perforation and peritonitis and one case had concurrent third compartment 
ulcers. One animal had an enteritis with concurrent hepatic lipidosis; Clostridium 
perfringens type A with the gene for enterotoxin was isolated from intestinal 
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contents. There was one case of anaplastic liver carcinoma with metastasis to 
internal lymph nodes. One animal was euthanized with neurologic signs and had 
severe hepatic cirrhosis of unknown etiology. Hepatic encephalopathy was 
suspected. 
 
Six animals had primary lesions in the urogenital system. There were three cases 
of urinary tract obstruction; one had a ruptured bladder due to urolithiasis (though 
stone composition was not determined), one had a urethritis with rupture but no 
stone detected, and the third case had silica uroliths and an Enterobacter sp. 
cystitis. There was one case of chronic glomerulonephritis with no underlying 
cause identified. One animal was diagnosed as intersex with bilateral ovotestes, 
female internal tubular structures, and masculinization of the external genitalia. 
One animal was diagnosed with a spindle cell sarcoma of the kidney that had 
metastasized to the lung and pleural surface. 
 
Twenty-three adult llamas had primary lesions of the nervous system. Eighteen 
animals had lesions consistent with meningeal worm infection; however, 
parasites were directly observed in only two cases. The brain was affected in 
eight of the eighteen cases (44%). There were two cases of 
polioencephalomalacia. There was one case with evidence of chronic cervical 
spinal cord compression, one case of listeriosis, and one case with cerebral 
edema of unknown cause. 
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II.G: Found Dead 
Thirty llamas were found dead without previous illness reported by their owners, 
which comprised 24% of llama submissions. The mean age of llamas suffering 
unexpected death was 6.0 +/- 5.6 years and the median was 4 years with a 
range of 0-20 years. Six animals (20%) had no numerical age recorded. Twenty-
two cases were female (79%), one was an intact male (4%), 4 were geldings 
(14%), and three had no sex recorded (11%). BCS ranged from 1 to 4 out of 5, 
though 7 had no numerical BCS recorded. The median BCS was 1.5. The cause 
of death was determined in 24 cases (80%). 
  
The most common cause of unexpected death in llamas was emaciation, with 9 
cases (32%). Liver fluke infection was the next most frequent cause of sudden 
death, affecting 6 cases (20%). Three cases had degenerative changes in the 
heart resulting in sudden death. There were two cases of suspected toxicity: one 
each involving copper and lead. There were two animals found dead with rupture 
of the pulmonary artery.  
 
II.H: Found Recumbent 
Twenty-nine llamas were found recumbent, comprising 23% of total llama 
submissions. The mean age of down llamas was 6.6 +/- 4.6 years with a median 
of 4 years. Two animals had no numerical age recorded. Fourteen cases were 
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female (48%), one was an intact male (3%), 10 were geldings (34%), three were 
unspecified males (10%), and one had no sex recorded (3%). A cause of death 
was determined in 27 cases (93%). 
 
The most common cause of death in llamas initially found down was meningeal 
worm, affecting 12 cases or 41% of recumbent llamas. Other causes of death in 
this subset included 2 cases of parasitic enteritis involving strongyles and 
coccidia, 2 cases of spinal fractures, and 2 cases of intestinal perforation. The 
other 12 cases found down died from a variety of causes including Streptococcus 
septicemia, caseous lymphadenitis, chronic interstitial pneumonia, spiral colon 
volvulus, third compartment ulceration, first compartment impaction, ulcerative 
stomatitis and esophagitis, urethral rupture, Listeria encephalitis, and bacterial 
meningitis. 
 
II.I: Ancillary Testing 
Ninety-four aerobic cultures (75%) were performed on swabs of organs and/or 
serosal surfaces; 38 were positive and the bacteria isolated included 
Enterococcus sp., Staphylococcus spp., Streptococcus equi subsp. 
zooepidemicus., Streptococcus bovis, Listeria monocytogenes, Trueperella 
pyogenes, Actinobacillus spp., Bacillus sp., E. coli, Pseudomonas aeruginosa, 
Bordetella bronchiseptica, Haemophilus sp., Acinetobacter sp., and Enterobacter 
sp.. Nine anaerobic cultures were performed (7%); three were positive for 
  52 
Clostridium perfringens from intestinal contents and liver swabs from two cases 
with liver flukes were positive for a variety of anaerobes: Peptostreptococcus 
anaerobius, Bacteroides sp., Clostridium perfringens and Clostridium sordelli. 
Fifty-five Salmonella cultures were performed on pooled tissues (44% of cases) 
and one adult llama was positive for Salmonella enterica serotype Agona. 
Thirteen animals were tested (10%) for Mycobacterium avium subsp. 
paratuberculosis (5 by culture, 4 by PCR, and 4 by both methods) and all were 
negative.  
 
Forty-four llamas (35%) were tested using PCR for bovine viral diarrhea virus 
and all were negative. Twenty animals (16%) were tested for rabies and all were 
negative. Five cases (4%) were tested for viral encephalitides and all were 
negative. One fetus underwent viral isolation but no viruses were identified.  
 
Fecal flotations were performed on eighty-six cases (69%) and 53 were positive 
(62% of floats performed). A variety of gastrointestinal parasites were identified, 
including small coccidia, Eimeria macusaniensis, Cryptosporidium spp., Giardia 
sp., undifferentiated strongyles, Nematodirus spp., Trichuris spp., Capillaria sp., 
Cooperia sp., Strongyloides sp., Dictyocaulus sp., and Moniezia sp.. Three 
immunofluorescence assays for Cryptosporidium and Giardia were performed 
(2%) and all were negative. 
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Discussion 
There was a distinct difference in the demographics of the alpacas and llamas 
submitted for necropsy during this time period. Although the range of ages was 
similar for both groups, the median age was 5 years for llamas and 1.5 years for 
alpacas. There were 96 alpaca crias, neonates, and fetuses compared to only 13 
llama crias, neonates, and fetuses, whereas the numbers of adult llamas and 
alpacas were similar (101 and 102 respectively). This may be due to a more 
vigorous breeding program among alpaca owners in the sampled region and 
different intended uses of the animals. It may be that llamas were more likely to 
be kept as pets or guard animals in small herds whereas alpacas in the area 
were more likely to come from larger farms and be used for breeding and 
showing. The distribution of male and female animals was similar between 
alpacas (58% female) and llamas (54% female); however, intact males were 
more common in the alpaca group (29% compared to 6% among llamas). This 
difference may be due in part to the ages of the animals submitted, since 
camelids often are not castrated before they are several years old. However, the 
difference was also apparent when comparing only adult llamas and alpacas; 
only 3% of adult male llamas were intact compared to 19% of adult male alpacas. 
This may also be due to differences in intended use. 
 
Although a specific cause of death could be identified in the majority of cases 
submitted (75% of all cases), the cause of abortion was determined in relatively 
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few fetuses, both alpaca and llama (only 5 out of 33 total). This can be frustrating 
for camelid owners and veterinarians, but this finding is similar to a previous 
report122 where 67% of camelid abortions were considered idiopathic. In addition, 
abortions may occur due to maternal stress without pathologic findings.15 
Interestingly, bovine viral diarrhea virus infection appears to be uncommon in 
camelids submitted to this veterinary diagnostic laboratory, with only one positive 
animal identified, an alpaca fetus examined in 2001.123 The virus was detected 
by viral culture of tissue homogenate as well as polymerase chain reaction. 
Concern over bovine viral diarrhea virus infection among alpacas arose in the 
mid-2000s after the identification of persistently infected crias.124, 125 Although a 
survey of alpaca owners in the United States identified that 25% of herds had at 
least one animal that was seropositive for BVDV and 6% had a persisently 
infected cria,126 there was only a single positive test in this study. There may also 
be a regional variation because no herds from Minnesota agreed to participate in 
the survey.126 However, in the present study, only 183 animals (51%) were tested 
by PCR, so there may have been additional positive animals and it is also 
possible that serologic testing (which was not performed) would have identified 
evidence of exposure to BVDV.  
 
The most common cause of death in alpaca neonates (age 0-14 days) was 
choanal atresia, a failure of normal craniofacial development that results in 
obstruction of the nasal passages.22, 23 This is considered a relatively common 
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congenital abnormality in camelids, though specific data on the prevalence of the 
condition is lacking. An informal survey of camelid practitioners estimated a 
prevalence of 0.75% of llama births and 0.48% of alpaca births.21 In this study, 
there were 13 cases of choanal atresia in alpacas (comprising 19% of alpacas <6 
months of age) and none in llamas. Most animals died or were euthanized within 
the first day of life; however, one animal lived to two months of age with bilateral 
obstruction of her choanae before dying from secondary suppurative 
bronchopneumonia. Concurrent congenital abnormalities were common; eight of 
the thirteen cases had additional craniofacial abnormalities such as brain, eye, 
and optic nerve malformations as previously described,23 one had spina bifida, 
and one had a genital anomaly (fused labia).25, 109, 127 During part of the study 
period, researchers at the University of Minnesota were actively studying camelid 
choanal atresia cases in order to attempt to identify a genetic component to the 
disorder, so there likely is a bias in the number of choanal atresia cases 
submitted.  However, any cases received from outside the standard area (e.g. 
from California or Michigan) were excluded from this retrospective study.  
 
Congenital malformations accounted for a total of 21 deaths among alpacas 
when the data from liveborn animals under 6 months of age was combined (31% 
of this age group and 9% of all alpaca submissions). A list of the congenital 
defects reported in camelids has been previously published.26, 128, 129 After 
choanal atresia, the most common abnormalities in this study were related to 
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malformation of the spinal column. Vaughan et al. described a male alpaca with 
deformities in his coccygeal spine which passed the abnormalities to eight of his 
offspring, and the report included one unrelated case of cervical vertebral 
malformation in an alpaca cria.130 The much larger number of congenital defects 
noted in alpacas versus llamas in our study is likely due to the much lower 
numbers of llama neonates and crias submitted for evaluation, as previously 
discussed, rather than a true difference in the incidence of such defects. In 
general, alpacas and llamas appear to have higher incidences of congenital 
malformations than other species.129, 131 This may be a consequence of a 
reduced genetic pool caused by large scale decimation of camelid herds during 
the Spanish conquest of the Andes132, 133 as well as selective breeding for color 
and fiber quality.134, 135 Llamas may have been under less selection pressure for 
fiber characteristics, since that is not their primary use. 
 
Septicemia was considered the cause of death in 11 alpaca crias under six 
months of age (16% of that age group). However, in contrast to other species 
such as calves or foals that are primarily affected in the neonatal period (<4 
weeks of age),136-139 the median age at death was 6 weeks. Previous reports on 
the clinical progression of septicemia in crias have found other differences 
between camelids and other species. For instance, septic crias often do not 
display the clinical signs such as fever, recumbency, or lack of suckle reflex 
which are considered classic for sepsis in other species. Additionally, 
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hematologic and biochemical measurements can remain within reference 
intervals even in cases of culture-confirmed sepsis.104 Similar to the results in the 
present study, Dolente et al. identified E. coli, Enterococcus sp., and Listeria 
monocytogenes as the most frequent causes of septicemia.104 Additionally, in 
this study there was often no obvious portal of entry for the bacteria, nor was 
there evidence of an umbilical infection in any case, while Dolente et al. identified 
only a single cria with an abnormal umbilicus,104 suggesting that this is not a 
common source of neonatal septicemia in camelids. 
 
As a whole, bacterial infections accounted for 47 of 234 cases of alpaca mortality 
(20%), including 19 of 38 crias age 2 weeks to 6 months (50%) and 18 of 102 
adult alpacas (18%). In addition to the septicemia described above, there were 
also cases of bacterial pneumonia, caseous lymphadenitis, other abscesses, 
peritonitis and pleuritis, encephalitis and meningitis, systemic and neurologic 
listeriosis, and enteritis. Bacterial infections have been previously described as 
the most common cause of death or referral of camelids to tertiary hospitals.140 
This was true of alpacas in this study, but in llamas bacterial infections comprised 
only 11 of 125 causes of mortality (8.8%). Both parasite infections and 
inflammatory conditions were more frequent than bacterial infection as a cause of 
death in llamas (Table 4, Figure 4).  
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Caseous lymphadenitis (CLA), caused by Corynebacterium pseudotuberculosis, 
has been occasionally described in camelids141-144 and was an infrequent cause 
of death in this study, with four total cases (1%) among adult alpacas and llamas. 
Two of the alpacas were submitted from a single herd in a two-month period. The 
llama lived in a pasture with sheep, but it was not possible to determine the 
specific source of infection from the histories provided. However, spread may 
occur when camelids are in contact with sheep or goats or when shearing 
equipment is not thoroughly disinfected.131 Anderson et al. monitored an 
outbreak of CLA in a North American alpaca herd and only external abscesses 
were identified,141 in contrast to the findings in the present study where all four 
cases had internal abscesses. Data from South American alpaca herds showed 
that internal abscessation may have a predilection for renal lymph nodes but in 
contrast to sheep, alpacas did not appear to develop frequent lung lesions.142 
Experimental inoculation of alpacas with Corynebacterium pseudotuberculosis 
resulted in a similar predilection for abscessation of renal lymph nodes.143 To the 
contrary, none of these cases in the present study had involvement of the renal 
lymph nodes and two animals had pulmonary abscesses.  
 
“Alpaca fever,” as bacteremia and polyserositis caused by Streptococcus equi 
subsp. zooepidemicus is sometimes known,10, 140, 145 was an infrequent cause of 
death in this study, affecting one adult llama (0.8%) and two adult alpacas 
(0.8%), though there were an additional two adult alpacas diagnosed with 
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Streptococcus spp. septicemia without concurrent evidence of polyserositis. 
Contrary to previous reports that most affected animals were under 3 years of 
age,10 the affected animals were 3.5, 4.5, and 10 years old. Alpaca fever can 
occur as a herd outbreak;10, 26 although all of the cases in this report resulted in 
mortality in single animals from a given location. However the histories included 
with the submissions of these cases did not state whether there were other sick 
animals on the property at the same time.  
 
Enteritis with isolation of Clostridium perfringens was an infrequent diagnosis in 
this study, accounting for four cases (2 alpaca youngsters, one adult alpaca, and 
one adult llama). Clostridium perfringens type A was isolated from each of these 
cases, though only three cases were positive for the genes for toxin production 
(two for the !2 toxin, one for enterotoxin). In Peru, clostridial enteritis is 
considered the leading cause of death among neonatal alpacas8 and often 
occurs in conjunction with coccidial infection. Damage to the intestines from 
coccidia may allow proliferation of C. perfringens, as has been demonstrated in 
chickens.146 However, C. perfringens type A and even the gene for the !2 toxin 
can be isolated from normal intestinal contents and the contribution to disease is 
not always clear.147, 148 
 
Hepatic lipidosis and derangements of glucose metabolism are a common 
concern in sick and hospitalized camelids due to inherent differences in their 
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metabolism, including decreased insulin production and peripheral insulin 
resistance.40, 46, 47, 51, 67, 149 Under experimental conditions, animals with additional 
metabolic stressors such as pregnancy and particularly lactation were more likely 
to develop hepatic lipidosis during feed restriction.52 However, lipidosis has also 
been identified in very young crias and was present in 12% of cria necropsies at 
Oregon State University.40 In our study, hepatic lipidosis was considered the 
primary cause of death in 8 adult alpacas, 7 of which were female. An additional 
7 adult female alpacas had a secondary diagnosis of lipidosis. There was not 
enough information in the record to accurately determine how many of these 
animals were currently lactating. Among the 4 cases of hepatic lipidosis in alpaca 
youngsters (aged 6-18 months), all 4 were female, though at this age the 
metabolic drains of pregnancy and lactation are likely not playing a role. In 
contrast, the two cases of hepatic lipidosis in crias (under 6 months of age) 
occurred in male animals. Whether or not hepatic lipidosis was considered the 
primary cause of death, there were 23 alpacas with hepatic lipidosis (10% of 
alpacas) but only two llamas (1.6%). The reason for the species difference is 
unclear; however, if the population of llamas was less likely to be reproductively 
active, those llamas may have been at lower risk of developing lipidosis. 
 
Emaciation was considered the cause of death in 19 alpacas (8%) and 12 llamas 
(10%). Some of these animals had underlying conditions such as gastrointestinal 
parasitism or dental abnormalities that may have reduced their ability to digest 
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and absorb nutrients; however, protein-energy malnutrition likely also played a 
role.150 Animals with increased energy expenditures such as growth, lactation, 
and pregnancy are at higher risk of developing protein-energy malnutrition, and 
cold weather also increases the energy needed to maintain a normal 
temperature.150 Twenty-seven of the 32 animals that died with evidence of 
emaciation were submitted between October and March, suggesting that the cold 
winters in the Upper Midwest contributed to mortality; however, there was no 
nutritional information available in the necropsy reports. Routine observation of 
body condition score by camelid owners may be hampered by dense fiber10, 150 
and hands-on evaluations should be performed on a monthly basis to identify 
animals in need of supplemental nutrition. 
 
Dental disease may contribute to decreased feed intake and subsequent 
emaciation. Bony swellings of the mandible are commonly identified in camelids16 
and are frequently caused by tooth root abscesses.151-153 However, dentition was 
remarked upon in only 8 cases (2% of total submissions; 4 adult llamas and 4 
adult alpacas). There were two cases with fractured incisors, two cases of wave 
mouth, two cases of overly worn molars, one case of severe incisor 
malalignment, and one case with chronic abscessation of the root of the third 
molar. Because the small number of animals diagnosed with dental abnormalities 
in this study does not match the frequency of antemortem diagnosis of dental 
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disease, it is possible that closer attention to the oral cavity during necropsy may 
be warranted, particularly in cases where animals are emaciated. 
 
Gastrointestinal parasites, particularly nematodes11, 154, 155 and coccidia5, 8, 107, 156-
163 are commonly identified in camelids and can be a cause of serious economic 
loss.11 In this study, the primary cause of death was gastrointestinal parasitism in 
thirteen alpacas (6%) and three llamas (2%). Furthermore, semi-quantitative 
fecal flotation was performed on 158 alpacas and 86 llamas and was positive in 
81 cases (51%) and 53 cases (62%), respectively. Some parasite infections are 
likely to be incidental; however, as discussed above, parasite burdens may have 
played a role in the death of a subset of the animals that died due to emaciation. 
Despite frequent identification of parasite burdens, only a small proportion of 
cases had gross evidence of infection with the Haemonchus contortus, 
Ostertagia, Trichostrongylus (HOT) complex. Eight animals (2%) showed 
evidence of thickened glandular mucosa in compartment 3 similar to 
ostertagiosis of cattle, while there were only two llamas diagnosed with severe 
haemonchosis with anemia. The frequent use of anthelmintics for suppressive 
deworming and meningeal worm prevention has led to recent evidence of 
anthelmintic resistance in camelid nematodes;164-167 however, it is not possible to 
determine whether resistance played a role in the deaths of animals in this study. 
Although gastrointestinal parasitism is clearly an important cause of morbidity 
and mortality, it may no longer be possible to rely solely on chemical treatment 
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for prevention. Eimeria macusaniensis  (E. mac) is a species of large coccidia 
that can cause serious disease and even sudden death in adults as well as 
crias.6, 159 E. mac was the primary cause of death in five alpacas (one cria and 
four adults), but it was not identified in any llamas. The reason for the species 
difference is unclear; however, the flotation technique used in our study and 
histopathology are not the most sensitive method to identify the heavier E. mac 
oocysts4, 168 and it is possible that low levels of E. mac were missed.  
 
Aberrant larval migrans caused by the white-tailed deer parasite 
Parelaphostrongylus tenuis, also known as meningeal worm, is considered a 
common cause of neurological disease of camelids living in endemic areas.27-32, 
169-172 At the teaching hospital at the Ohio State University, one third of cases 
presenting with neurologic signs were diagnosed with meningeal worm.30 
Similarly, when alpacas and llamas are considered together in this study, there 
were 24 cases of meningeal worm out of 43 total fatal diseases involving the 
nervous system (56%). However, there were only five cases of meningeal worm 
in alpacas (2% of total submissions) compared to 18 in llamas (14% of total 
submissions). The reason for this difference in unclear, though it may be related 
to the frequency of prophylactic deworming. Routine meningeal worm prevention 
may be more common in larger breeding herds of alpacas compared to smaller 
farms with a few animals. Eight of the llama cases (44%) and four of the alpaca 
cases (80%) had involvement of the brain as well as the spinal cord, although 
  64 
cases presenting for treatment at Ohio State less commonly had neurologic signs 
referable to the brain (such as seizures, head tilt, or cranial nerve deficits).30 It 
may be that animals undergoing necropsy represent a more severely affected 
group. 
 
Liver flukes, specifically Fascioloides magna (the large American liver fluke), 
caused the death of 4 of 234 alpacas (1.7%) and 11 of 125 llamas (8.8%). 
Additionally, there were 3 adult llamas with evidence of fluke infection but a 
separate cause of death was identified. All of the cases of liver flukes came from 
central and northeastern Minnesota, consistent with the known range of F. 
magna in the state,173 and seven of the llamas were from a single location over a 
one year period. There are limited previous reports of F. magna in camelids,105, 
174, 175 but the clinical course of the disease appears to be more similar to that of 
cattle than to small ruminants, since the flukes are able to develop to maturity.174 
Two of 18 animals in this study with evidence of F. magna had concurrent mural 
endocarditis.105 
 
Neoplasia accounted for the cause of death in 15 of 234 alpacas (6.4%) and 5 of 
125 llamas (4%), for an overall prevalence of 5.5% (5.8% if excluding abortions). 
This is similar to a prevalence of 7% in camelids reported by the Purdue 
Veterinary Medical Diagnostic Laboratory176 and 6.9% by the Oregon State 
University Veterinary Diagnostic Laboratory.177 The mean age of alpacas with 
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neoplasia was 7.8 +/- 5.6 years (range fetus – 22 years) and median was 6.5 
years. In contrast, the mean age of llamas with neoplasia was 12.8 +/- 2.9 years 
(range 9-15 years).  
 
Round cell tumors (RCTs), which include lymphosarcoma and primitive 
malignant round cell tumors,36, 178 are the most frequently reported form of 
neoplasia in camelids.3, 15, 36-38, 176-184 In a retrospective evaluation of camelid 
neoplasia, RCTs accounted for only 5 of 40 tumors identified (12.5%); however, 
biopsy samples were also included.177 In our study, RCTs made up 73% of all 
neoplasia as cause of death in alpacas. The mean age of alpacas with RCTs 
was 6.0 +/- 4.1 years of age with a median of 5.5 years. Three alpaca cases 
were under 2 years of age and all three were diagnosed with RCTs. This is in 
contrast with other forms of neoplasia and although the total number of alpacas 
with other neoplastic diseases was low, the animals affected had a mean age of 
12.4 +/- 6.8 years and a range of 6-22 years with a median of 10.75 years, which 
is consistent with past studies.177 There were only two llamas with round cell 
tumors (accounting for 40% of neoplastic disease among llamas) with a mean 
age of 12 years. The age difference in alpacas and llamas with RCTs is 
consistent with previous reports;37, 177 however, the reason for the different 
signalment between species is unclear. Using immunohistochemistry, 4 tumors 
were identified as B cell lymphoma (based on CD20 or CD79  staining) and one 
was categorized as T cell lymphoma (based on CD3 staining). This ratio of B cell 
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to T cell malignancy is similar to other reports.37 The remaining eight tumors 
either did not undergo immunohistochemistry or were negative to most markers 
and may represent primitive malignant round cell tumors (RCTs). 
 
A variety of neoplasms other than RCTs have been described in llamas and 
alpacas.185-195 However, in this population of alpacas, all fatal neoplasms other 
than RCTs involved the gastrointestinal tract. This is in contrast to the population 
from Purdue, where the second most common site of neoplasia was the 
pulmonary parenchyma, accounting for 23% of camelid tumors.176  
 
Ulceration of the third compartment (C3) is considered a common disease of 
camelids,3, 14, 15, 108 and although this condition can lead to perforation of the 
stomach and peritonitis, it may also be found incidentally in some cases.3 In our 
population of alpacas, C3 ulcers were less common than previously reported and 
were an infrequent cause of death. Previous reports have determined the 
prevalence of C3 ulcers as a cause of death to be 5%, with ulcers additionally 
contributing to mortality in more than 20%.14 In a series of 45 animals at Oregon 
State University from whom gastric contents were sampled, 14 had ulcers 
(31%).108 Our data showed that there were two out of 234 alpacas (0.9%) with 
C3 ulcers as the primary cause of death, whereas there were seven of 125 
llamas (5.6%) that were considered to have died due to C3 ulceration. An 
additional 13 alpacas ranging in age from 5 months to 12 years had evidence of 
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C3 ulceration for an overall prevalence of 6% in alpacas. Among llamas there 
were another 8 cases with evidence of C3 ulcers, giving an overall prevalence of 
12% in New World camelids in this study.  
 
Interestingly, although C3 ulceration was less common than expected, there 
were 6 alpacas (2.5%) and 6 llamas (4.8%) with ulceration of the esophagus 
and/or first compartment (C1). The C1 ulcers were considered of secondary 
importance in 4 of the llamas but no specific cause was identified. One llama 
youngster had concurrent evidence of disseminated intravascular coagulation 
and may have been septicemic, and one adult llama had widespread ulceration 
of the esophagus and C1. Among the alpacas, 4 had evidence of septicemia or 
other concurrent disease processes such as generalized hemorrhage, and one of 
these had evidence of fungal invasion of the compartment wall. The other two 
alpacas with C1 ulceration had evidence of renal compromise; one was a cria 
with hydronephrosis caused by an ectopic ureter and one was markedly 
dehydrated with elevated creatinine prior to death. The specific cause of the 
ulceration in these two cases is not known but may be related to uremia as is 
seen in other species, although dogs with uremic gastropathy develop edema 
and mineralization of the oral and glandular mucosa rather than ulceration of the 
esophagus.196  
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There were three cases of spontaneous (non-traumatic) pulmonary artery rupture 
in llamas (two adults and one youngster). This is rarely reported in the veterinary 
literature197-199 though it occurs in humans, most often secondary to pulmonary 
hypertension.200 Other known causes in humans include disorders of connective 
tissue such as Ehlers-Danlos syndrome or Marfan syndrome, infection (including 
bacteria, fungal, and mycobacterial), congenital malformation, or iatrogenic 
rupture during cardiac procedures.200 The llama youngster had evidence of a 
bacterial arteritis from which Actinobacillus sp. were isolated; however, there was 
no underlying disease identified in the other two cases. 
 
Of note was the fact that the urinary tract and respiratory tract were uncommon 
causes of death in the alpacas and llamas in our study. Urogenital system 
disorders accounted for 11 (5%) deaths among alpacas and 8 (6%) llamas, if 
abortions are excluded. There were two cases of glomerulonephritis without an 
underlying cause identified. Data from necropsies at Oregon State University 
suggests that this type of kidney disease may occur secondary to systemic 
inflammation.201 Urolithiasis was not a frequent finding, in contrast to sheep and 
goats, in which obstructive urolithiasis is a common presenting complaint and 
can result in death if not treated promptly.202, 203 Urolithiasis and urinary tract 
obstruction are reported in camelids204, 205 but the reason for a lower prevalence 
of disease compared to sheep and goats is unknown. There may be a regional 
variation in the prevalence of urolithiasis in camelids, with the Pacific Northwest 
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more heavily affected by silicate stones.201 Pulmonary disease was also an 
uncommon cause of death in this study. This is in contrast to similar necropsy 
retrospectives among other ruminants such as farmed deer and elk, where 
pneumonia was second only to trauma as a primary cause of death.111-113 
 
In both llamas and alpacas found dead, the two most commonly identified causes 
of death were emaciation and parasitism. However, bacterial infections, 
neoplasia, and hepatic lipidosis were also identified in animals that died 
unexpectedly, suggesting that camelids can develop severe systemic 
compromise without displaying clinical signs obvious enough to be recognized by 
owners. As previously mentioned, dense fiber may make observation of declining 
body condition score less obvious, which means that regular hands-on evaluation 
is important to identify animals in need of a workup for weight loss. 
 
Acute recumbency (e.g. a down camelid) is a frequent presenting complaint for 
veterinary evaluation. In endemic areas, many camelid owners consider 
meningeal worm to be the primary differential. In this study, the single most 
common diagnosis in llamas that were found down was meningeal worm, 
accounting for 38% of down llamas submitted for necropsy. In contrast, only 8% 
of down alpacas were diagnosed with meningeal worm and in fact abnormalities 
with the digestive system (42%) were more commonly the cause of eventual 
death in an alpaca found recumbent. This confirms the need for a thorough 
clinical workup for a down camelid. 
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Previous investigation into the causes of mortality in camelids is limited. A survey 
of alpaca and llama owners in the United Kingdom showed that the most 
common causes of death were believed to be trauma, intestinal disorders, 
perinatal disorders including congenital defects and failure of passive transfer, 
and vitamin E/selenium deficiency.206 Because this was a survey of owners, 
many of the causes of death were unconfirmed by necropsy. In our study, 
intestinal disorders and perinatal causes of death were also common. In contrast, 
in our study traumatic death was not a frequent diagnosis (9 of 234 alpacas and 
6 of 125 llamas), although it is possible that trauma cases were not submitted for 
necropsy. While selenium toxicosis was diagnosed in two alpaca crias, there was 
only one suspected case of white muscle disease. 
 
A brief report on the causes of camelid mortality in Canada3 described digestive 
disorders followed by neurologic disorders as the most common causes of death 
in camelids over 1 year of age. In our study, although digestive disorders 
(including hepatic disorders) were the most common cause of mortality for both 
alpacas and llamas, the second most common cause of death in alpacas 
involved multisystemic disorders, primarily consisting of severe emaciation and 
septicemia.  
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Limitations to this retrospective analysis include variations in the method of 
necropsy, the supervising pathologist, and the specific data recorded. Although 
42% of the animals submitted came through the Veterinary Medical Center 
(VMC), the overall numbers may still reflect an accurate representation of fatal 
conditions that would be encountered in the field because many local practices 
encourage the use of the VMC for after-hours emergencies. There is likely a 
degree of location bias, as owners closer to the UM-VDL may have been more 
willing to submit animals for necropsy; however, animals were submitted from 
throughout the state of Minnesota and from nearby areas of Wisconsin and Iowa 
(Figures 5-7).  
 
Conclusions 
In conclusion, although there are many different causes of death among alpacas 
and llamas, many of the disorders resulting in mortality can be at least partially 
prevented with attention to husbandry. Close attention to the provision of 
adequate nutrition and frequent monitoring of body condition score may reduce 
the likelihood of death due to emaciation. Rational parasite control programs 
could also help lower mortality rates. Bacterial infections are a common problem 
in young alpacas (under 6 months of age) and ensuring adequate passive 
transfer of antibodies may help prevent life-threatening infections.
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Footnotes 
a. R Development Core Team. (2010) R: A language and environment for 
statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 
Retrieved from http://www.R-project.org  
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Table 1: Results of 234 alpacas submitted for necropsy evaluation to the UM-
VDL grouped by age and by primary body system involved in cause of death. 
Age groups are neonate (<2 weeks), cria (2 weeks to 6 months), youngster (6 
months to 18 months), and adult (>18 months).  
 
 Age Group 
 
Primary Body System Fetus Neonate Cria Youngster Adult Total 
Multisystemic 1 2 12 7 20 42 
Musculoskeletal  1 5  5 11 
Respiratory  16 3 2 5 26 
Cardiovascular  3 1 4 4 12 
Hemolymphatic 1  1 3 14 19 
Digestive  4 13 13 38 68 
Urogenital 28 2  3 6 39 
Nervous   3 4 10 17 
Total 30 28 38 36 102 234 
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Table 2: Results of 125 llamas submitted for necropsy evaluation to the UM-VDL 
grouped by age and by primary body system involved in cause of death. Age 
groups are neonate (<2 weeks), cria (2 weeks to 6 months), youngster (6 months 
to 18 months), and adult (>18 months).  
 
 Age Group 
 
Primary Body System Fetus Neonate Cria Youngster Adult Total 
Multisystemic 1 1 1  19 22 
Integumentary     2 2 
Musculoskeletal   1  5 6 
Respiratory     8 8 
Cardiovascular  1  2 5 8 
Hemolymphatic   1  3 4 
Digestive  1 1 7 30 39 
Urogenital 2 1  1 6 10 
Nervous  1 1 1 23 101 
Total 3 5 5 11 101 125 
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Table 3: Results of 234 alpacas submitted for necropsy evaluation to the UM-
VDL grouped by age and by primary pathophysiologic process involved in cause 
of death. Age groups are neonate (<2 weeks), cria (2 weeks to 6 months), 




Process Fetus Neonate Cria Youngster Adult Total 
Developmental 3 15 6  2 26 
Degenerative   1  1 2 
Metabolic   2 4 8 14 
Neoplastic 1   2 12 15 
Nutritional   3 7 12 22 
Bacterial  4 19 6 18 47 
Viral 1    3 4 
Parasitic  1 5 2 13 21 
Fungal  1   1 2 
Inflammatory  1  5 15 21 
Idiopathic 24     24 
Toxic  1 1   2 
Traumatic  2  1 6 9 
Vascular 1   2 4 7 
Miscellaneous  1 1 7 6 15 
Unknown  2   1 3 
Total 30 28 38 36 102 234 
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Table 4: Results of 125 llamas submitted for necropsy evaluation to the UM-VDL 
grouped by age and by primary pathophysiologic process involved in cause of 
death. Age groups are neonate (<2 weeks), cria (2 weeks to 6 months), 
youngster (6 months to 18 months), and adult (>18 months).  
 
Pathophysiologic 
Process Fetus Neonate Cria Youngster Adult Total 
Developmental  1 1  1 3 
Degenerative    1 3 4 
Metabolic      0 
Neoplastic     5 5 
Nutritional   1  16 17 
Bacterial  2 1 1 7 11 
Viral      0 
Parasitic   1 7 28 36 
Fungal      0 
Inflammatory    2 20 22 
Idiopathic 2     2 
Toxic     2 2 
Traumatic     6 6 
Vascular 1 1   2 4 
Miscellaneous  1   10 11 
Unknown   1  1 2 




Figure 1: Graph showing result of 204 alpacas (excluding abortions) submitted for necropsy evaluation to the UM-VDL 
grouped by age and by primary body system involved in cause of death. Age groups are neonate (<2 weeks), cria (2 
weeks to 6 months), youngster (6 months to 18 months), and adult (>18 months).  
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Figure 2: Graph showing result of 122 llamas (excluding abortions) submitted for necropsy evaluation to the UM-VDL 
grouped by age and by primary body system involved in cause of death. Age groups are neonate (<2 weeks), cria (2 




Figure 3: Graph showing result of 204 alpacas (excluding abortions) submitted for necropsy evaluation to the UM-VDL 
grouped by age and by primary pathophysiologic process involved in cause of death. Age groups are neonate (<2 weeks), 





Figure 4: Graph showing result of 122 llamas (excluding abortions) submitted for necropsy evaluation to the UM-VDL 
grouped by age and by primary pathophysiologic process involved in cause of death. Age groups are neonate (<2 weeks), 
cria (2 weeks to 6 months), youngster (6 months to 18 months), and adult (>18 months). 
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Figure 5: Map showing the distribution of location of alpacas and llamas 
submitted to the UM-VDL for necropsy from 2001-2011. Darker colors represent 
higher numbers of cases per county (range 1-41). 
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Figure 6: Map showing the distribution of location of alpacas submitted to the 
UM-VDL for necropsy from 2001-2011. Darker colors represent higher numbers 
of cases per county (range 1-41). 
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Figure 7: Map showing the distribution of location of llamas submitted to the UM-
VDL for necropsy from 2001-2011. Darker colors represent higher numbers of 
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Summary 
New World camelids (NWCs) have reduced insulin production and peripheral 
insulin sensitivity compared to other species. Sick NWCs commonly develop 
hyperglycemia, hyperketonemia, hypertriglyceridemia, and hepatic lipidosis, but 
little is known about pancreatic function in this state. Our aim was to use 
epinephrine to induce transient fat mobilization in healthy NWCs and then 
intravenous arginine stimulation testing (IVAST) to assess pancreatic ! and " cell 
function. The hypothesis was that NWCs in a state of epinephrine-induced fat 
mobilization would have reduced insulin secretion and increased glucagon 
secretion as measured by IVAST. Fourteen healthy llamas were used in a control 
design and intravenous catheters were placed. IVAST involved intravenous 
administration of 67 mg/kg 10% arginine HCl. Blood samples were collected at 
0,2,3,4,5,7,10,15 and 20 minutes post-arginine injection for plasma glucose, 
insulin and glucagon measurement. All 14 animals underwent a baseline IVAST. 
36 hrs later feed was withheld for 12 hours and then each animal received 1 
µg/kg epinephrine IM (t=-60). One hour after epinephrine administration IVAST 
was repeated (t=0). Serum NEFAs, ketones, and triglycerides were measured at 
t=-60 and at t=0. Epinephrine induced mild elevations in NEFAs, ketones, and 
triglycerides (p<0.0001). Baseline insulin (but not glucagon) was lower after 
treatment with epinephrine (p<0.01). During IVAST the AUC at 10 minutes was 
lower for [insulin] (p<0.05) and higher for [glucagon] (p<0.0001) after epinephrine 
treatment. The results of this study may reflect a direct effect of !-adrenergic 
stimulation on the pancreas. Our findings may provide insights into changes that 




New World camelids are prone to developing disorders of fat mobilization such 
as ketoacidosis, elevations in non-esterified fatty acids, hypertriglyceridemia, and 
hepatic lipidosis, even in the absence of risk factors such as pregnancy, 
lactation, or obesity.40, 42, 44, 96-98 These metabolic derangements often occur as a 
secondary condition in sick and hospitalized camelids, but can frequently be the 
medical issue that requires the most intensive treatment.9, 39, 43, 44, 98 Interestingly, 
transient fat mobilization can be induced in camelids by treatment with 
epinephrine49 and it is possible that this model of induced fat mobilization could 
be utilized in order to study the metabolic responses of New World camelids in a 
state of abnormal metabolic function. 
 
Camelids are known have low resting levels of insulin,42, 46, 51 a decreased 
release of insulin in response to hyperglycemia,46, 67, 149 and decreased glucose 
clearance with the administration of exogenous insulin47, 48, 51, 67 when compared 
to other species. It is not known whether these responses are further reduced in 
sick camelids with fat mobilization, but the widespread occurrence of fat 
mobilization disorders44, 45 along with hyperglycemic disorders such as marked 
stress hyperglycemia and hyperosmolar syndrome39, 43, 46 suggests that there 
may be an association. Further evaluation of camelid energy metabolism, 
particularly insulin sensitivity and pancreatic function, will enable better 
understanding of the development of disorders of glucose and lipid metabolism 
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as well as help target treatment of these conditions to prevent mortality.  
 
Techniques such as intravenous glucose tolerance testing46, 67 and 
hyperinsulinemic euglycemic and hyperglycemic clamping51 have been 
performed to investigate insulin and glucose dynamics in healthy camelids. 
However, no studies have been performed investigating how glucose tolerance, 
insulin production, and insulin sensitivity are affected in sick camelids in a state 
of fat mobilization. This may in part be due to the long procedure time of currently 
available testing methods and their potential to adversely affect recovery from the 
animal’s original illness, due to the need to induce supraphysiologic levels of 
glucose and insulin in the bloodstream during these testing procedures. 
 
Insulin secretagogues such as arginine have been used to study diabetes 
mellitus in humans60, 76, 81, 83 and have also been used in veterinary species 
including cats,92-94 pigs,207, 208 foals,84-86 sheep,207, 209-211 and cattle.87-91, 207 
Intravenous infusion of arginine stimulates the release of insulin and glucagon 
from the pancreas and this response can be used to assess ! and " cell function. 
The arginine stimulation test is a short procedure that allows blood insulin and 
glucose concentrations to remain at physiological levels and consequently can 
be used to study changes in pancreatic function in clinical cases. The purpose of 
this study was to use the intravenous arginine stimulation test (IVAST) to 
characterize and compare the pancreatic ! and " cell responses in healthy 
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camelids with those in a state of epinephrine-induced fat mobilization. The 
hypothesis to be tested was that camelids in a state of fat mobilization would 
have decreased insulin production and increased glucagon production by the 
pancreas. 
 
Materials and Methods 
Animals 
The study included 15 healthy llamas, 10 from the research herd at Oregon State 
University and 5 client-owned animals at the University of Minnesota. The study 
used a non-randomized crossover design in which each animal acted as its own 
control. Experiments were conducted in October and November 2011. There 
were 12 females and 3 neutered males with a mean age of 10.2 +/- 6.2 years 
(range 3-22 years). Median body condition score on a five point scale was 4 with 
a range of 2 to 5. Prior to the study all animals were screened by physical 
examination and found to be healthy. The llamas were maintained on a diet of 
grass hay. All procedures were approved by the Institutional Animal Care and 
Use Committees at Oregon State University and the University of Minnesota. 
 
Arginine Stimulation Test Method 
Procedures used for the IVAST were based on methods previously reported in 
humans60, 76 and piloted in New World camelids.95 A 14 gauge cathetera was 
placed in the right jugular vein of each llama (for medication administration and 
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blood sample collection). The next day, the baseline intravenous arginine 
stimulation test (IVAST) was performed. Llamas were tied in pairs in their stalls to 
maintain a calm state. Baseline blood samples were taken into heparinized and 
EDTA tubes immediately prior to the IVAST. Arginine HClb at 67 mg/kg was 
administered intravenously over 30 seconds, with t = 0 set at the time at which 
half the solution had been given. Venous blood samples were taken into EDTA 
tubes at t = 2, 3, 4, 5, 7, 10, 15, and 20 minutes. Blood glucose was immediately 
measured at each time point using a handheld glucometerc previously validated 
for use with camelid whole blood samples.51 The heparinized and EDTA tubes 
were immediately placed on ice and centrifuged promptly. The resulting plasma 
was then stored at -80 C until processing.  
 
Fat Mobilization 
After a 36-hour rest period from the first IVAST, the llamas were held off feed for 
12 hours. Access to water was not restricted. Sixty minutes prior to the start of 
the IVAST (t = -60) a pre-epinephrine blood sample was taken into heparinized 
and EDTA tubes. The llamas then received 1 µg/kg epinephrined by 
intramuscular injection into the semimembranosus muscle in order to induce 
transient fat mobilization. The dose of epinephrine was chosen based on the 
results of a study that evaluated the responses of serum fat fractions in llamas to 
treatment with intramuscular epinephrine.49 Sixty minutes after treatment with 
epinephrine, the IVAST procedure was repeated (t = 0). A randomized crossover 
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design was not utilized in case the epinephrine treatment caused a delayed 
effect of fat mobilization on pancreatic response. 
 
Analytes 
The heparinized plasma from t = 0 and t = -60 was analyzed for triglycerides, "-
hydroxybutyrate, and non-esterified fatty acids (NEFAs). EDTA plasma from 
each time point was kept frozen at -80 °C until analyzed for insuline and 
glucagonf by radioimmunoassay, within 3 months of collection. 
 
Analysis 
For each time point insulin (I), glucagon (Gl), and glucose (G) were measured. 
For each animal baseline, (I0, Gl0, G0), peak response (Imax, Glmax, Gmax), and 
time to peak response (IPT, GlPT, GPT) were recorded. The incremental area 
under the curve (AUC) for insulin and glucagon were calculated during the first 
10 (AUC10) and the entire 20 minutes (AUC20) using the trapezoid methodg.  
 
Statistics 
Results were reported as median and range or mean +/- standard deviation 
depending on the distribution of the data. For all parameters, the normality of the 
data was evaluated using the Shapiro-Wilk test of normality. If the data were not 
normally distributed, the data was transformed with the natural log for calculation 
of the paired t-test to evaluate the difference between control and epinephrine-
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treated values and the results were reported as geometric mean +/- geometric 
standard deviation. If the data were normally distributed, results were reported as 
mean +/- standard deviation and the paired t-test was performed on un-
transformed data. Unless otherwise stated, paired t-tests were one-sided with the 
hypotheses that the control values of insulin were greater than the values after 
treatment with epinephrine and that the control values of glucagon and glucose 
were lower than the values after treatment with epinephrine. The changes in the 
fat fractions during the control experiment, after an overnight fast, and after 
treatment with epinephrine were analyzed with the Friedman rank sum test 
followed by the Wilcoxon signed rank test using the Bonferroni correction. A 
repeated measures ANOVA was used to compare insulin, glucagon, and glucose 
at each time point (t=0, 2, 3, 4, 5, 7, 10, 15, 20) before and after epinephrine 
treatment. For all values p < 0.05 was considered significant. 
 
Results 
Epinephrine treatment, but not overnight fasting, successfully induced mild 
elevations in "-hydroxybutyrate (BHBA), non-esterified fatty acids (NEFAs), and 
triglycerides (TGs) (Table 1, Figure 1). Results of the intravenous arginine 
stimulation test are presented in Table 2. After epinephrine treatment, both I0 and 
peak insulin were significantly lower (p = 0.012 and p = 0.012 respectively) and 
peak glucagon was significantly higher (p = 0.0024) when compared to the 
IVAST performed without epinephrine treatment (Figure 2, Figure 3). There was 
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no significant difference in Gl0 before and after epinephrine treatment. The insulin 
area under the curve (AUC) at 10 minutes was significantly lower after 
epinephrine treatment (p = 0.03) and the glucagon area under the curve (AUC) at 




To the authors’ knowledge, this is the first description of the use of the arginine 
stimulation test to examine pancreatic function in New World camelids. In other 
species such as humans, cats, sheep, and cattle, arginine administration 
stimulates release of both insulin and glucagon by the pancreas. Arginine alters 
the cell membrane potential in " cells as the positively-charged amino acid is 
transported across the membrane77, 212, 213 and stimulates calcium influx,77, 78, 214 
resulting in insulin secretion. In humans, arginine stimulation results in a roughly 
three-fold increase (from baseline) in peripherally sampled insulin and 
glucagon60, 76 with no significant differences between control and diabetic 
subjects when blood glucose levels are not controlled. However, when blood 
glucose is tightly regulated by insulin infusion or dextrose infusion, diabetic 
patients show reduced insulin secretion and exaggerated glucagon secretion in 
response to arginine stimulation in comparison to control subjects.81 Cats have a 
more vigorous response to arginine stimulation than humans, with a six-fold 
increase in insulin and glucagon from baseline,93 whereas cattle have shown a 
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range from 4-fold to 10-fold increases in insulin depending on the study and a 
roughly 5-fold increase in glucagon.87, 88 When directly comparing change from 
baseline, this study indicates that healthy llamas show a similar response to 
arginine stimulation as seen in healthy humans. In contrast, previous studies of 
pancreatic function in camelids using intravenous glucose tolerance testing46 and 
hyperglycemic clamping51 have shown that healthy llamas and alpacas have 
lower insulin secretion in comparison to other species. It is important to note, 
however, that basal blood glucose values in llamas are higher than in healthy 
humans. In humans, hyperglycemia potentiates insulin secretion in response to 
non-glucose secretagogues (such as arginine) and similar patterns of response 
to arginine in healthy and diabetic patients are observed unless blood glucose 
values are uniform between the two study populations.60, 76, 81 Thus it is possible 
that if the blood glucose level was lowered to that of humans in order to directly 
compare the IVAST response at the same level of glycemia, llamas may have an 
overall decreased insulin response to arginine.  
 
New World camelids are prone to disorders of fat and glucose metabolism39, 43-46, 
97 and their poor pancreatic " cell responsiveness and glucose intolerance are 
thought to contribute. The study of New World camelids with naturally occurring 
fat mobilization is limited by the availability of appropriate numbers of clinical 
cases and the difficulty in performing research procedures that may have 
negative consequences in client-owned animals. In order to study the effect of 
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IVAST testing in animals with fat mobilization, this study aimed to induce fat 
mobilization in healthy animals through treatment with epinephrine. In addition to 
its cardiovascular effects, epinephrine plays an important role in the regulation of 
fat and glucose metabolism. In times of stress, epinephrine directly increases 
plasma glucose levels by promoting glycogenolysis in the liver. However, it also 
causes peripheral insulin resistance,215, 216 thereby reducing tissue uptake of 
glucose by insulin-mediated mechanisms. At the same time, it increases the 
levels of plasma lipids by stimulating the activity of hormone-sensitive lipase to 
release NEFAs and decreasing clearance of triglycerides through inhibition of 
translation of lipoprotein lipase.217 In addition, despite a resulting rise in blood 
glucose levels stimulated by catecholamine release, there is a direct inhibitory 
effect on insulin secretion by pancreatic " cells, mediated by !-adrenergic 
receptors.218-220 In the state of hypoglycemia, the sympathetic nervous system 
(including epinephrine release) is partially responsible for increasing blood 
glucose values and epinephrine itself also stimulates the release of glucagon by 
pancreatic ! cells.221  
 
In previous models,49, 52, 100 epinephrine but not cortisol was able to induce fat 
mobilization in treated animals, suggesting that endogenous catecholamine 
release may be important in the development of these disorders of metabolism. 
In the present study, epinephrine treatment resulted in mild elevations of fat 
fractions and the degree of fat mobilization was similar to a previous study in 
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llamas,49 based on the mean values of fat fractions 60 minutes after epinephrine 
treatment. In that study, the mean basal insulin level was lower before treatment 
(2.17 µU/ml) than reported here and increased slightly but significantly to a mean 
of 2.88 µU/ml 60 minutes after administration of epinephrine, rather than 
decreasing as in the study reported here. Cebra et al attributed that increase in 
insulin to compensation for the increase in plasma glucose levels;49 however, in 
the present study mean plasma glucose increased by 46% yet basal insulin 
decreased from 7.9 µU/ml to 5.7 µU/ml after treatment with epinephrine. A 
decrease in insulin in response to epinephrine is expected based on studies of 
continuous epinephrine infusion in other species,218-220, 222 though the effects of a 
single dose rather than an infusion could be different. Interestingly, although the 
epinephrine treatment resulted in mild elevations of fat fractions, elevated blood 
lipids themselves are expected to enhance insulin secretion56 rather than 
decrease it. It is possible that there may be less influence on insulin secretion 
due to the change in blood glucose after epinephrine administration because of 
the decreased responsiveness of the camelid pancreas to a glucose stimulus.46, 
51, 67 
 
During arginine stimulation testing, epinephrine-treated llamas with mild 
elevations in plasma NEFAs, ketones, and triglycerides showed a reduced acute 
insulin secretory response and an exaggerated acute glucagon secretory 
response, in comparison to their baseline measurement (see Figures 2 and 3). In 
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humans, the first phase of the insulin secretory response is highly correlated to 
the area under the curve of insulin release in response to arginine,80 whereas 
measuring the area under the curve for time periods longer than 10 minutes is 
likely to include some degree of second phase insulin secretion.76 In the current 
study the incremental area under the curve at 10 minutes for insulin was 
significantly lower after epinephrine treatment, while there was no significant 
difference at 20 minutes. A study in humans223 determined that epinephrine is a 
dose-dependent inhibitor of insulin secretion (as measured by the acute insulin 
response to arginine injection) when plasma glucose levels are held constant, 
which would be consistent with the findings in the present study. Similarly, 
epinephrine is a dose-dependent stimulator of glucagon secretion when plasma 
glucose levels are held constant,220 and in the data reported here the acute 
glucagon response to arginine was significantly higher after treatment with 
epinephrine. Plasma epinephrine levels were not quantified in this study, making 
it difficult to determine whether there is a direct correlation between epinephrine 
concentrations at the time of the IVAST and the attenuated insulin and 
exaggerated glucagon responses.  
 
It is not possible to determine from this study whether the changes observed in 
IVAST response after treatment with epinephrine were due to a direct effect of 
adrenaline on pancreatic function, or whether the effect of causing fat 
mobilization in healthy animals contributed to the differences seen. In ruminant 
 98 
species, the IVAST has been used to evaluate changes in pancreatic function in 
response to stressful environmental stimuli such as high or low temperatures. 
Similar to the epinephrine-treated llamas in this study, the environmental 
extremes resulted in decreased insulin secretion and increased glucagon 
secretion in response to arginine. The proposed mechanism for the stress-
induced changes in IVAST response seen in ruminants was increased 
sympathetic tone in response to environmental stressors.87, 88, 210, 211 
Interestingly, a pilot trial examining IVAST response in clinical cases of camelids 
with deranged fat mobilization also follows a similar pattern, whereby insulin 
response is decreased and glucagon response is increased after IVAST in 
comparisons to normal animals.95 This suggests that stress and the 
catecholamine response may be part of the mechanism by which pancreatic 
function is affected in sick camelids.  
 
Conclusions 
In conclusion, the IVAST was successfully used to evaluate pancreatic function 
in llamas. Healthy llamas showed a similar magnitude of insulin response to 
arginine as healthy humans. However, given previous evidence that camelid 
insulin secretion is reduced compared to other species,46, 51 this response may 
be due to potentiation of pancreatic " cells due to a higher baseline glucose level 
in camelids. Further investigation using a combination of IVAST and 
hyperglycemic clamping to better characterize camelid insulin secretion at 
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multiple blood glucose levels is warranted. Additionally, although the effects of 
epinephrine may be directly responsible for the decreased insulin secretion and 
increased glucagon secretion observed, similar findings in stressed animals of 
other species suggest that epinephrine may be part of the mechanism by which 
sick camelids develop derangements of glucose and lipid metabolism. Further 
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Table 1: Table showing median and range for B-hydroxybutyrate (BHBA), non-esterified fatty acids (NEFA), and 
triglycerides (TG) immediately before the control intravenous arginine stimulation test (IVAST), 60 minutes prior to second 
IVAST after a 12 hour fast (fasted), and 60 minutes after epinephrine injection immediately prior to the second IVAST 
(epinephrine-treated), in 15 llamas. Different superscripts represent values that are significantly different according to post 
hoc testing. Values of P ! 0.05 were considered significant. 
 
 Control Fasted Epinephrine-treated  
Fat Fraction Median Range Median Range Median Range p value 


































Table 2: Table showing insulin and glucagon parameters in 15 llamas during an intravenous arginine stimulation test 
(IVAST) with and without treatment with epinephrine 60 minutes prior to IVAST. I0, baseline plasma insulin concentration; 
Peak I, insulin peak response; AUC10, incremental area under the curve at 10 minutes; AUC20, incremental area under 






















  Control Epinephrine-treated  






SD p value 
I0 µU/ml 7.90 1.59 5.70 1.95 0.012 
Peak I µU/ml 26.08 1.57 21.72 1.77 0.012 
AUC10 insulin µU/ml/10 min 116.65 1.79 103.58 1.73 0.03 
AUC20 insulin µU/ml/20 min 240.62 1.92 221.41 1.93 0.10 
Gl0 pg/ml 47.82 1.32 53.06 1.42 0.13 
Peak Gl pg/ml 99.75 1.39 123.55 1.50 0.0024 
AUC10 glucagon pg/ml/10 min 341.72 1.90 538.79 1.73 <0.0001 
AUC20 glucagon pg/ml/20 min 634.39 1.88 962.95 1.85 0.0002 
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Figure 1: Bar chart showing median fat fractions immediately before control intravenous arginine stimulation test (IVAST), 
at 60 minutes prior to second IVAST after a 12 hour fast, and at 60 minutes after epinephrine injection immediately prior to 
the second IVAST, in 15 llamas. Error bars represent interquartile range. Different superscripts represent values that are 




Figure 2: Figure showing geometric mean of plasma insulin concentrations during intravenous arginine stimulation test 
(IVAST) with and without treatment with epinephrine 60 minutes prior to IVAST, in 15 llamas. Error bars represent 




Figure 3: Figure showing geometric mean of plasma glucagon concentration during intravenous arginine stimulation test 
(IVAST) with and without treatment with epinephrine 60 minutes prior to IVAST, in 15 llamas. Error bars represent 


















In the present study, New World camelids were affected by a wide variety of fatal 
disorders. In both alpacas and llamas, abnormalities of the digestive system 
including gastrointestinal parasitism, hepatic lipidosis, liver flukes, intestinal 
neoplasia, and gastrointestinal ulcers were the most frequently identified cause 
of death. Other causes of death in alpacas included emaciation and systemic 
bacterial infections, whereas the nervous system (primarily meningeal worm 
infection) was the second most common site of abnormalities among llamas. 
Congenital abnormalities accounted for more than 30% of deaths among alpaca 
neonates and crias, suggesting the need for additional studies on the genetic 
diversity of alpaca populations and the heritability of particular malformations 
such as choanal atresia. Many of the causes of death may be preventable with 
routine husbandry measures such as nutritional evaluation, frequent body 
condition scoring, and routine diagnostics to assess gastrointestinal parasite 
burdens. Results from this study will provide veterinarians with more information 
to better assist camelid owners with routine health maintenance practices such 
as nutrition and parasite control that will help reduce mortality. The description of 
common causes of death in this population of animals will help camelid 
practitioners identify aspects of management that need closer attention as well 
as help in the determination of likely differential diagnoses when faced with a sick 
animal. Further studies such as similar descriptions of common fatal diseases in 
other regions of the United States are necessary to provide a complete picture of 
the causes of mortality in New World camelids. 
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The IVAST technique is quick and comparatively simple to perform, so it has the 
potential to be used to evaluate pancreatic function in camelids in a variety of 
metabolic states including growth, pregnancy, lactation, and illness. Under 
control conditions, llamas in this study had a similar magnitude of insulin and 
glucagon release as healthy humans. However, the combination of a 
hyperglycemic clamp and IVAST could be used to better characterize insulin and 
glucagon secretion at several blood glucose levels to determine the degree to 
which the camelid pancreas is potentiated by circulating glucose. Additionally, 
because arginine induced insulin secretion, it is possible that intravenous 
arginine could be used as therapy to augment or replace exogenous insulin for 
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